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ABSTRACT 
 
The Relationship Between BMI and Asthma Is a Significant Health Concern Among 
Pre-Adolescent and Adolescent Children.  (August 2007) 
Jennifer Leah Furman, B.A., Texas A&M University 
Chair of Advisory Committee:  Dr. W. Alex McIntosh 
 
 
 
 In the U.S., the prevalence rates of obesity and asthma have increased over the 
past 20 years and led to speculation that a correlation exists between them.  Most of the 
research that has been conducted on the association between obesity and asthma has 
been done so in adults.  Little data are available on this association in children.  Obesity 
and asthma are associated with significant morbidity and mortality risk.  Concern that 
the prevalence of overweight and asthma in children will persist and/or worsen in 
adulthood has prompted the current study.  This study analyzed the association between 
asthma and allergy prevalence and measures of overweight, dietary intake, supplement 
use, ethnicity, child’s guardian, mother’s education level, and whether the mother 
smokes among children aged 9 to 11 years and 13 to 15 years.  This study also analyzed 
the association between the use of prescription asthma and allergy medication and 
asthma and allergy diagnosis, measures of overweight, dietary intake, supplement use, 
ethnicity, guardian, mother’s education level, and whether the mother smokes.   
The findings of this study revealed that non-White children had greater odds of 
asthma diagnosis and were more likely to use asthma medications.  A positive 
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correlation was found between asthma diagnosis and allergy diagnosis and between 
asthma diagnosis and the use of allergy medication.  Positive correlations were found 
between asthma diagnosis and BMI category, subscapular skinfold thickness, and waist 
circumference among children 9 to 11 years old.  Age and weight were found to be 
inversely correlated with asthma diagnosis among children 13 to 15 years old.  BMI 
category was found to be positively associated with asthma diagnosis among males, but 
not among females.  Asthma diagnosis in females was not found to be significantly 
correlated with any of the variables.  Dietary intake, multi-vitamin/mineral and omega-3 
fatty acid supplementation, guardian, waist/hip ratio, mother’s smoking habit, and 
mother’s education level were not found to be significantly correlated with asthma or 
allergy diagnosis or with asthma or allergy medication use.  A significance value of 
p<0.05 was used for all analyses. 
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CHAPTER I 
INTRODUCTION 
 
The world is plagued with a plethora of chronic diseases.  Over the past 20 years, 
the U.S. has seen particularly rapid and simultaneous rises in the prevalence rates of both 
asthma (1-3) and obesity (4-8).  Given the similar increases in both of these chronic 
diseases over the recent years, there has been much speculation that there may be a 
relationship between the two.  Most of the research that has been conducted on this 
subject has been done so in populations of adults, but children have also been affected 
by the increases in asthma and obesity.  To date, limited research is available on the 
effects of obesity and comorbid asthma in children and adolescents. 
 The most recent estimates report that almost one-third of Americans are obese 
and more than half are either overweight or obese (4).  There are many possible 
explanations for the recent rise in overweight and obesity.  The rise may be attributed to 
a combination of internal factors, including genetic and physiological, and external 
factors, including environmental, behavioral, cultural, and social.  While there is 
research to support that all of these factors may be involved in the etiology of 
overweight and obesity, a study by Fiore et al. points to external factors as the major 
contributors (9).  Parental obesity may be the most important risk factor for child 
obesity, which likely reflects an interaction between genetic, lifestyle, and behavioral  
factors (9, 10).  Obesity gives rise to many comorbidities in children and adults,   
____________ 
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including type 2 diabetes, hypertension, dyslipidemia, and respiratory problems among 
many more (4, 9, 11-13, 5).  The increasing burden of obesity and its comorbidities 
results in increased health care utilization (12) and ultimately increased financial burden 
(14).  Most recent reports estimate the cost of obesity in the U.S. to be $99 billion per 
year, more than half of which is attributable to hospital visits, emergency department 
visits, and medication usage (12, 15, 16). 
 In addition to overweight and obesity, asthma prevalence has also been on the 
rise in both the adult and child populations.  Between 1980 and 1994, the prevalence of 
asthma increased by over 100% among Americans (1).  Asthma prevalence more than 
doubled among children less than 18 years of age during this time period (2).  Current 
estimates report that 6.5 million children currently suffer from asthma and more than 
two-thirds of these children experience at least one asthma attack per year (2).  It has 
been reported that asthma exacerbations in the previous 12 months have contributed to a 
significant number of school absences, limitations in physical activity, and impaired 
functioning due to sleep disturbances (17, 18), which may then contribute to physical 
and mental dysfunction.   
 Asthma is defined as a chronic inflammatory disease of the respiratory tract.  It is 
characterized by coughing, wheezing, breathlessness, airway obstruction, chest tightness, 
and bronchial hyperresponsiveness (19, 20).  Like obesity, there are many possible 
factors involved in the development of asthma, including a combination of genetic, 
lifestyle, environmental, and socioeconomic factors (3, 21-24).  Family history of asthma 
or allergy as well as a personal history of allergy seems to be the most important 
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predictors of asthma (10, 11, 25, 26).  As many as 85% of school-aged children have 
been reported to have asthma combined with allergies to airborne triggers (27).  
Immunoglobulin E (IgE) and histamine are involved in the pathogenesis of allergic-
asthma (28) and are responsible for acute asthma exacerbations and inflammation (29).  
Children with a combination of asthma and rhinitis use more health care resources than 
children with asthma alone (30).  Allergic asthma usually establishes in childhood, 
increases throughout childhood and adolescence, and peaks in the second decade of life 
(29).   
 Diet and obesity are gaining interest as risk factors for the development of 
asthma (3, 6, 10, 31).  Many studies report that asthma severity, control, and prevalence 
may be influenced by increasing body mass index (BMI) (32, 33).  Some researchers 
suggest that excess body fat may have different effects on asthma in boys versus girls, 
and children versus adults (7, 21, 31, 33, 34).  This subject will be further explored in the 
following chapter.  Dietary intake, particularly inadequate intake of antioxidants and 
essential fatty acids, may be involved in the pathophysiology of asthma.  Decreased 
intakes of fresh foods such as fruits, vegetables, and fish may have contributed to the 
decline in the intake of these micronutrients, mainly vitamin C and omega-3 fatty acids.  
Survey results regarding nutrient intake can be misleading and may not account for 
variations among individuals in a group.  For example, research conducted at the 
Beltsville (Maryland) Human Nutrition Research Center, United States Department of 
Agriculture (USDA) reported that the average intake of vitamin C among children under 
the age of 18 years exceeds the dietary reference intakes (DRI) for vitamin C; however, 
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this is actually only being achieved by 73% of the children (35).  Vitamin C and omega-
3 fatty acids suppress inflammation associated with asthma by targeting prostaglandins 
and leukotrienes, respectively (10, 36), both of which will be described in further detail 
in the following chapter.   
Asthma is the leading cause of illness and disability in children (5).  Asthma can 
adversely affect an individual’s ability to perform daily functions as well as negatively 
impact psychosocial health.  Children miss more days from school due to asthma than 
any other chronic childhood disease (17, 18).  Reports have estimated that as many as 
60% of children have experienced school absences due to asthma, with an average of 10 
missed school days per year (18).  Asthma is also the leading cause of hospitalizations 
among children (22).  The risk of hospitalization is compounded by the presence of 
asthma comorbidities, especially rhinitis.  Children with asthma and comorbid allergic 
rhinitis utilize more health care resources than children with asthma alone (30).  Risk for 
hospitalization increases with increasing asthma severity and medication use, and 
contributes to increasing financial burden and asthma mortality risk.  Most recent reports 
estimate the annual cost of asthma in the U.S. to be $11 billion (36), with 
hospitalizations and medication use accounting for the majority of this (18). 
Acute asthma poses a considerable risk for death, despite advancements in 
awareness and understanding of the disease.  Disease severity, level of disease control, 
and the presence of psychosocial disturbances may increase the risk for asthma mortality 
(37).  The risk for asthma death increases with age, with the greatest rates among 
adolescents (2).  Chronic lower respiratory disease is one of the ten leading causes of 
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death among adults and children according the most recent reports by the National 
Center for Health Statistics (5). 
The National Heart, Lung, and Blood Institute (NHLBI), the Global Initiative for 
Asthma (GINA), and the National Asthma Education and Prevention Program (NAEPP) 
all provide guidelines that help to identify asthma, determine asthma severity, and 
establish appropriate treatment.  The Asthma Control Test (ACT) and the Asthma 
Therapy Assessment Questionnaire (ATAQ) are valuable tools that may be used to 
determine the level of asthma control and are helpful in determining if therapeutic goals 
are being achieved. 
Children with asthma that is complicated by excess body weight may require 
special care and treatment from health care providers.  Obese asthmatics suffer from a 
greater number of symptoms, greater frequency of symptoms, greater medication use, 
and greater limitation in daily activity, which is often indicative of greater asthma 
severity (14).  Individually, asthma and obesity contribute to a decline in the quality of 
life of those afflicted with the diseases.  The decline in quality is much greater in obese 
individuals with asthma compared to those with asthma or obesity alone (38). 
Like asthma, obesity is an inflammatory disease.  Adipose tissue releases 
substances, such as leptin, that stimulate the production and release of inflammatory 
factors.  Some of these inflammatory factors include interleukin (IL)-6, tumor necrosis 
factor (TNF)-alpha, C-reactive protein (CRP), and chemokines (6, 33, 39).    Many 
researchers suspect that the increase in obesity prevalence has contributed to the increase 
in asthma prevalence by way of an inflammatory mechanism.  The release of 
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inflammatory factors may adversely affects the respiratory system (19, 40), which may 
then lead to the development of asthma.  More information regarding these factors and 
their mechanisms will follow.  Other researchers believe that obesity gives rise to asthma 
via a mechanical mechanism rather than an inflammatory mechanism.  Obesity, 
especially central obesity, exerts mechanical stress on the airways, which leads to a 
sequence of events that result in asthma.  This is also explored in the following chapter. 
Bronchial hyperresponsiveness (BHR), a common symptom of exercise-induced 
asthma is more pronounced in individuals with excess weight.  BHR is also a common 
symptom of other respiratory conditions, so its presence alone may not indicate an 
asthma diagnosis (41, 42).  If an individual is suspected of having asthma, he should 
undergo further analysis.  Confirmation of asthma should include lung function tests in 
order to determine appropriate treatment (17, 39).   
Many of the studies conducted on the relationship between asthma and obesity 
provide inconsistent results.  Cross-sectional studies, by design, make it difficult to 
determine a causal relationship between the two because sequence of onset cannot be 
determined.  A handful of studies have demonstrated that obesity precedes the onset of 
asthma, thus supporting the hypothesis that obesity is involved in the development of 
asthma.  However, in view of the fact that there is limited information available, it is 
important that more research be conducted, especially among children. 
The data used in this thesis were drawn from the Parental Time, Role Strains, 
Coping, and Children’s Diet and Nutrition project conducted by Texas A&M University, 
College Station between July 2001 and June 2002, with permission by the authors (43).  
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Concern about the rise in asthma and overweight among children and concern that these 
health conditions may continue or perhaps even worsen in adulthood has led me to 
investigate the subject further.  Given the limited availability of research regarding the 
relationship between asthma and overweight in children and the inconsistencies among 
this research, it is the objective of this thesis to investigate the relationship between 
asthma and measures of overweight, allergies, dietary intake of vitamin C and omega-3 
fatty acids, the use of dietary supplements, ethnicity, with whom the child lives, parent 
education, and whether the parent smokes..  The relationship between these variables 
and allergies will also be investigated.  This thesis will analyze the relationship between 
asthma and allergy medication use and the variables listed above in addition to the 
presence or absence of asthma and allergy diagnosis.  Analyses performed in this thesis 
are controlled for age and gender.  The current data set was chosen and is valuable 
because it contains randomly drawn subjects and includes variables regarding household 
structure, medication and dietary supplement use, as well as dietary intake.  The 
availability of these factors allows for the ability to research the possible effects of 
genetic, cultural, behavioral, and external factors on chronic childhood conditions. 
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CHAPTER II 
LITERATURE REVIEW 
 
This chapter contains a literature review that explains in more detail about the 
rising prevalence of obesity and asthma in the U.S.  It includes a detailed description of 
each disease as well as explanations on their adverse effects in those afflicted.  A special 
section is devoted to research that explains the possible relationship between asthma and 
obesity.   
Overweight and Obesity 
Prevalence 
The prevalence of obesity has been on the rise for the past two decades and has 
now become an epidemic.  Most recent estimates suggest that the proportion of U.S. 
adults who are obese is equal to 30%, an increase from 23% in 1994 (4).  This means 
that almost one-third of U.S. adults are obese.  If we also consider those who are 
overweight, this proportion increases to 65% (4).  In other words, more than half of U.S. 
adults are either overweight or obese.  In terms of actual numbers, this is equal to 130 
million Americans (1). 
This trend is not exclusive to adults, though.  American children and adolescents 
have also experienced a significant rise in the prevalence of overweight over the past 
two decades (7, 8).  The prevalence of overweight among children increased more than 
100% from 1980 to 1994 (6).  From 1980 to 2002, the prevalence of overweight among 
6 to 11 year-olds more than doubled from 7% to 16%, and the prevalence of overweight 
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among 12 to 19 year-olds more than tripled from 5% to 16% (4, 5).  The most recent 
data from the 2003-2004 National Health and Nutrition Examination Survey (NHANES) 
report that 17.1% of children and adolescents between the ages of 2 and 19 years are 
overweight (8).  Overweight prevalence in the state of Texas has been reported to be 
21.3% for elementary-aged girls, 23.6% for elementary-aged boys, 16.7% for middle 
school-aged girls, and 21.4% for middle school-aged boys (44).  Not only is it alarming 
that more children and adolescents are overweight, but they are now even more 
overweight than children and adolescents of the past (13).  The severity of this disturbing 
trend is reflected by its inclusion in the Healthy People 2010 objectives.  The goal is to 
decrease the prevalence of overweight among children to 5% by the year 2010 (16, 45).  
Overweight prevalence also appears to be higher among Hispanics, African Americans, 
those living in urban areas (3), and those living in poverty (9).  This suggests an 
interaction of several possible factors, which will be discussed below. 
What determines whether a person is of a healthful weight or is overweight?  
BMI, which is dependent on age and gender, is just one way to assess body fat (46).  
BMI examines weight for height and is more accurate for measuring body fat than by 
weighing alone (4).  BMI correlates relatively well with body fat in children, but does 
differ with age (10).  Other measures that may be used to assess body fat include 
bioelectrical impedance analysis (47), waist circumference, waist/hip ratio, relative 
weight, skin folds, dual energy x-ray weighing, and tomographic scans, all of which 
show a high correlation to body composition (48).  Waist circumference and waist/hip 
ratio are becoming more important as measures of central adiposity (40), but BMI is the 
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measurement most commonly used in epidemiologic studies (34, 40) because it is easy 
and inexpensive to measure (47).  However, BMI tends to overestimate body fat in those 
with large muscle mass, common among men (49), and underestimates body fat in those 
with a normal weight for height but with high adiposity (4, 47).   
In adults, a BMI of 25 and above, but below 30 is considered overweight.  A 
BMI of 30 and above is considered obese.  Due to variations in growth and development 
among children, obesity is more difficult to define compared to adults (9).  Because all 
children do not develop at the same rate, the Centers for Disease Control and Prevention 
(CDC) provides growth charts for children between the ages of 2 and 20 years, which 
are specific for age and gender (50).  For children, BMI is calculated the same way as for 
adults.  Then, it is plotted on the growth curves to obtain a percentile score.  If the 
child’s BMI is between the 85th and the 95th percentiles, he is considered at risk for 
overweight.  If the child’s BMI is in the 95th percentile or greater, he is considered 
overweight (50).  Because the classification of overweight for children is different from 
that of adults, the terms overweight and obese are commonly used interchangeably by 
researchers when referring to the child’s weight or BMI.   
Risk Factors 
Obesity may result from an interaction between behavioral, cultural, 
environmental, genetic, physiological, and social factors (5, 16).  According to one 
study, obesity that originates from internal effects, such as genetic or physiological 
factors, accounts for less than 10% of all cases, and obesity that originates from external 
effects, such as behavioral, cultural, environmental, or social factors, accounts for more 
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than 90% of all cases (9).  A few studies report that the most important risk factor for 
childhood overweight is parental weight (9, 10), which may be caused by a combination 
of genetic, lifestyle, or behavioral factors (10).  Environmental factors such as changes 
in entertainment, safety, transportation, and work habits have all contributed to 
decreased opportunities to participate in physical activity (9).  Behavioral factors such as 
physical inactivity and increased consumption of convenience foods and increases in 
portion sizes have contributed to the energy imbalance that is believed to be a major 
contributor to the rise in overweight and obesity in the U.S. (4).  Whatever the causes of 
overweight in children and adolescents may be, it is well known that compared to 
children with a healthful weight, overweight children have a much higher risk for adult 
obesity and the morbidities associated with it (9, 19). 
Consequences 
Overweight and obesity are of concern among Americans of all ages because 
they are well known to be associated with a number of morbidities (5, 39).  Obesity is 
believed to be an inflammatory state that may contribute to the onset of many chronic 
diseases (33).  Some of these include type 2 diabetes, heart disease, cancer, 
hypertension, respiratory problems, dyslipidemia, stroke, gall bladder disease, gout, 
osteoarthritis (4, 5, 9, 11-13), and psychosocial problems (13).  Likewise, compared to 
normal weight children, overweight children have a higher risk of developing 
psychosocial disorders, dyslipidemia, diabetes, asthma, hypertension (9, 13, 51, 52), and 
accelerated growth (9) in adulthood and in childhood.  The recent increase in type 2 
diabetes is believed to be the result of the recent rise in obesity (13).  Obesity is also 
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thought to be responsible for half of adolescent hypertension cases (13).  Psychosocial 
problems, such as depression, low self-esteem, negative self-image, and withdrawal 
from peers, may be the result of discrimination experienced by overweight individuals at 
school, at work, in health care, and in social settings (40).  Obese children and adults 
also have a higher risk for reflux, sleep disturbances, and respiratory symptoms (19, 40, 
53). 
 The distribution of body fat also seems to be an important indicator of morbidity 
risk.  Abdominal obesity especially is associated with a high level of morbidity (39, 49).  
Waist circumference may be measured in addition to BMI to enhance assessment of 
morbidity risk (39).  Increasing triceps skinfold measurement may be associated with an 
increase in LDL-cholesterol and triglycerides and a decrease in HDL-cholesterol (13).  
With increasing weight, mortality becomes an increasing risk as well (4, 5, 39, 40).  For 
example, in the U.S. in 2000, obesity was the cause of 400,000 deaths, most of which 
were likely preventable (4, 39). 
BMI and its comorbidities are significant predictors of greater risk of 
hospitalization (12).  According to a study by Raebel et al., obese individuals had more 
than three times the risk of hospitalization than non-obese individuals (12).  In general, 
obese individuals have higher rates of hospitalizations, outpatient visits, and prescription 
drug use (12).  They consume more asthma, allergic rhinitis, cardiovascular, diabetes, 
and thyroid medications (12).  The prevalence of chronic diseases associated with 
obesity, increases in medications available, and increases in the consumption of current 
medications may have contributed to increases health care utilization (5). 
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Considering all of the morbidities associated with overweight and obesity, along 
with the increased risk of health care utilization and prescription drug use, it is no 
surprise that the increasing prevalence of overweight and obesity in the U.S. is 
associated with great financial burden.  The direct and indirect costs associated with 
overweight and obesity are considerably high (14).  Because individuals who are 
overweight or obese have higher rates of health care and prescription drug use compared 
to individuals who are not overweight or obese, they have higher hospitalization, 
prescription, and overall healthcare costs (12).  In 2000, the cost of obesity in the U.S. 
accounted for 7% of total healthcare costs.  Most recent estimates report that obesity 
costs the U.S. $99 billion per year, 52% of which is related to medical costs (12, 15, 16). 
Asthma 
Prevalence 
Another increasing concern is asthma.  Like overweight and obesity, the 
prevalence of asthma has increased considerably over the past two decades.  From 1980 
to 1994, the prevalence of asthma among Americans of all ages increased by over 100%.  
By 1995, asthma affected almost 15 million Americans.  Currently those affected by 
asthma represent 7% of the American population (1).  Though the trend is evident 
among all races, age groups, and genders, the most substantial increases were among 0 
to 4 year-olds, with a 160% increase, and among 5 to 14 year-olds, with a 74% increase 
(3).  Asthma is the most common chronic disease in childhood (6), and it is a major 
cause of disability (2) and medical emergencies (54) in children.  Between 1980 and 
1996, the prevalence of asthma among children under 18 years of age more than doubled 
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to historically high rates from 3.6% to 7.5%, with a peak in 1995 (2).  In 2005, 12.7%, or 
9 million children, had received a diagnosis of asthma, and 70% of these children, 6.5 
million, still currently suffered from the disease.  According to a study conducted by 
Petronella et al., asthma prevalence in Texas was reported to be 13.9% (55).  Almost 
two-thirds of children currently suffering from asthma have experienced at least one 
asthma attack in the previous 12 month period (2).  Large-scale studies have reported as 
many as five or more asthma attacks per year in up to one-third of children with asthma 
(18).  Asthma prevalence among children remains historically high, although it tends to 
improve from childhood into adulthood (27). 
It is possible that the current estimation of asthma does not represent the true 
asthma prevalence.  Asthma may be undiagnosed in individuals who exhibit mild 
symptoms of asthma, or individuals who have asthma-like symptoms could be falsely 
diagnosed as having asthma when they do not (48).  Depending on self-report to 
determine asthma prevalence may underestimate the actual prevalence of asthma (17).  
Many practitioners and researchers disagree on the definition of asthma; therefore, those 
who may have asthma may not have been diagnosed (17, 33).  Individuals who have 
asthma, but who have not received a diagnosis, may not be receiving the treatment they 
may need to control their symptoms.  Undiagnosed asthma was defined by one study 
based on the report of cough, wheeze with or without a cold, wheeze with dyspnea, 
cough or wheeze with exercise, and chest tightness on three occasions in the past 12 
months (56).   
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The prevalence of undiagnosed asthma remains high despite increasing 
awareness of the disease (57).  The possibility of undiagnosed asthma is high among all 
ethnic groups (58).  A study by Clark et al. reported that 9% of children with asthma 
symptoms had not been diagnosed with the disease.  They also found that only 25% of 
the individuals exhibiting mild symptoms, 35% exhibiting moderate persistent 
symptoms, and 26% exhibiting severe persistent symptoms had been prescribed 
medications to treat their asthma.  In addition, of the individuals being treated with 
medication, 74% were still experiencing symptoms (42).  Another study conducted by 
Nolte et al.  reported undiagnosed asthma prevalence among individuals at baseline to be 
as high as 67% (59).  On average, research suggests that, among American children, the 
prevalence rate of undiagnosed asthma is between 5% and 20% (56). 
 One study suggests that asthma improves with age from childhood (27).  This, in 
fact, may not be due to actual improvement in symptoms, but perhaps may be due to an 
increased perception of asthma status.  This could lead to an underestimation of asthma 
in adolescents because they have less inclination to seek care for their asthma (58).  
Another possible explanation for undiagnosed asthma is due to the symptoms 
themselves.  Respiratory symptoms in general are better tolerated than other conditions, 
such as pain in the chest or the back.  Someone experiencing pain may be more likely to 
report this problem to a health care provider rather than respiratory problems (57).  Also, 
basing a diagnosis of asthma only on recent symptoms can underestimate the prevalence 
of asthma, which may subsequently lead to undertreatment of the disease (23).   
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 Individuals with undiagnosed asthma may be experiencing symptoms so mild 
they may not be recognized to be asthma, or the symptoms may be mistaken for other 
respiratory diseases (57).  For example, one study reported that symptoms in 
undiagnosed individuals did not impair functional status, suggesting a mild form of the 
disease (56).  Undiagnosed individuals with moderate or severe persistent asthma have 
functional impairment similar to moderate or severe persistent asthmatics with a 
diagnosis, suggesting that undiagnosed individuals were more tolerant of their symptoms 
or may not have had access to appropriate care (56).  Quality of life (QOL) seems to be 
impaired in both individuals with asthma diagnosis as well as in those without asthma 
diagnosis.  QOL appears to be lower in those with a diagnosis compared to the 
undiagnosed group, suggesting that the undiagnosed group has a milder form of asthma 
(60). 
 Data regarding the presence or absence of atopy in undiagnosed cases of asthma 
are conflicting.  While one study reports that children with undiagnosed asthma are more 
likely to have allergic disease (17), another reports the opposite.  Joseph et al. reported 
that children with diagnosed asthma are more likely to report allergies (56).  Research 
also suggests that children with undiagnosed asthma suffer from a greater extent of 
morbidity compared with diagnosed children (17). 
 Many studies report an underestimation of asthma prevalence and, subsequently, 
undertreatment of the disease (42, 59, 60).  Clark et al. reported that more than half of 
subjects were not being treated appropriately according to NAEPP recommendations 
(42).  Not only were individuals with asthma symptoms not being diagnosed, but also 
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were individuals with asthma symptoms and concomitant allergic rhinitis (59).  As many 
as one-third of the individuals suffering from asthma and allergy symptoms in a study 
conducted by Nolte et al. had not been diagnosed with either conditions.  Likewise, 
almost half of these individuals were not being treated but would have benefited from 
treatment according to international guidelines (59). 
Definition 
Asthma, derived from the Greek word “asthmaino” meaning “panting or 
gasping” was first described by Hippocrates (460-377BC).  Galen was the first to 
describe the relationship between the upper and lower airways and the etiological link of 
asthma to bronchospasm (61).  In 1911, histamine was described in the pathophysiology 
of asthma (61).  In 1966, IgE and its role in mast cell activation were discovered (61).  
These discoveries suggested a role of mast cells in airway hyperresponsiveness in 
asthma (61). 
Today, asthma is defined as a chronic inflammatory disorder, which affects the 
airways.  It is often characterized by recurrent episodes of wheezing, breathlessness, 
chest tightness, airway obstruction, and excessive bronchial responsiveness (19, 20).  
Researchers have shown elevated levels of inflammatory factors in individuals with 
persistent asthma, even when the individuals express no symptoms (62).  When exposed 
to a trigger, T-helper lymphocytes stimulate the release of arachidonic acid-derived 
eicosanoids, called leukotrienes, from inflammatory cells via lipoxygenase action.  
These leukotrienes are believed to be major mediators in the development of asthma 
through an inflammatory mechanism (36). 
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Arachidonic acid can also be converted to thromboxane A2 and prostaglandin E2 
(PGE2) via the action of cyclooxygenase.  The PGE2 activates T-helper lymphocytes, 
which stimulate the production of IgE from inflammatory cells (36).  IgE is responsible 
for reactions to allergens, and elevated levels of IgE have been reported in individuals 
with asthma (36).  Asthma has been recognized as a disease involving inflammatory 
cytokine release, including IL-4 and IL-5.  Another cytokine, IL-6, has been recognized 
in obese asthmatics and may suggest a relationship between obesity and asthma through 
an inflammatory mechanism (53).     
According to NAEPP guidelines, the diagnosis of asthma is based on the 
presence of episodes of asthma symptoms and a demonstration of at least partial 
reversibility of airway obstruction (48).  Symptoms include wheeze that lasts two or 
more consecutive days; chronic cough that responds to bronchodilation and that persists 
for 3 to 6 weeks in the absence of rhinitis or sinusitis; and sleep disturbance with 
dyspnea, cough, or wheeze (42).  These symptoms must be exhibited on at least three 
occasions in the past 12 months for a clinical diagnosis of asthma (60).  The diagnosis 
should be confirmed by lung function testing, including response to bronchodilation and 
exercise or chemical challenge (42).  Other potential diagnoses should be excluded 
before the diagnosis of asthma is given (48).  Frequent pneumonia or bronchitis in a non-
smoker, a family history of atopy, or food sensitivity should suggest the possibility of 
asthma (22).  Traditionally, physicians have diagnosed asthma based on the individual’s 
self-report of asthma symptoms.  Epidemiological questionnaires mirror this mode of 
diagnosis (60).    
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Asthma is characterized by inflammation and narrowing of the airways.  It can 
occur in response to certain triggers, such as allergens, exercise, infections, or 
respiratory irritants (5).  An asthma attack may be characterized by coughing, wheezing, 
pain or tightness in the chest, shortness of breath, and/or increased mucus production (2, 
5, 19).  In treatment or diagnosis of asthma, it is important to determine environmental 
history in order to identify potential triggers (22).  Exacerbation of the aforementioned 
symptoms at night is indicative of asthma (22).  
Risk Factors 
Asthma may be the result of a combination of environmental, genetic, lifestyle, 
and socioeconomic factors (3, 21-24).  Environmental factors that have been noted as 
potential causes of asthma include allergens, air pollution, respiratory infections, and 
tobacco smoke (63, 64).  Family history of asthma, family history of allergies, and 
gender all potentially increase asthma risk (64).  Other factors such as crowding, drug 
use, poverty, poor access to health care, and psychosocial problems, among many more, 
increase the risk of asthma morbidity (22).  Asthma risk is especially important in 
children, whose airways are anatomically different from those of adults.  Children have a 
shorter neck, a larger tongue, and larger tonsils and adenoids, all of which may influence 
airway obstruction (19). 
Family history of asthma or allergy, exposure to tobacco smoke, rhinitis, and 
obesity have been recognized by many as the most important risk factors for asthma (6, 
11, 25), with allergy posing the biggest threat for asthma onset and asthma symptoms in 
children and adults (10, 11, 25, 26).  As mentioned previously, childhood asthma is 
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usually allergy-related (26).  Most allergic reactions are mediated by IgE and involve the 
action of histamine.  IgE antibodies recognize and bind to an invading antigen then 
stimulate mast cells to release histamine.  Histamine binds to H1 receptors on smooth 
muscle cells in the lungs, which causes bronchoconstriction (28).  In one study, 81% of 
asthma patients had at least one positive skin prick test (65).  Allergic asthma increases 
in prevalence from childhood into adolescence and peaks in the second decade of life 
(29).  Allergic reactions mediated by IgE are generally responsible for acute asthma 
symptoms and chronic airway inflammation (29).  It has been reported that as many as 
85% of school-aged children have asthma combined with allergy to airborne triggers 
(27).  Bloom and Freeman reported that 11% of children in the U.S. under the age of 18 
years suffered from allergies in the previous 12 months (66).  Non-Hispanic White 
children are more likely to be have respiratory allergies than Hispanic or non-Hispanic 
Black children (66).  The prevalence of respiratory allergies is also influenced by region 
and by parent education level.  Children in the South (15%) are more likely to have 
respiratory allergies than are children in the Midwest (11%), in the Northeast (10%) or in 
the West (9%) (66).  Children whose parents have at least a high school diploma are 
more likely to have respiratory allergies (66). 
It has already been noted that many factors may be attributed to the development 
of asthma.  More of these factors include income, education level, residence, and race.  
People with lower educations levels and lower incomes, regardless of race, have been 
reported to experience more asthma symptoms (23).  Residence in urban areas is an 
important risk factor for asthma morbidity and mortality, but this may be influenced 
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more by socioeconomic status or race rather than place of residence (24).  Asthma 
prevalence is generally higher in minority children compared to White children (17); 
although, White children have shown a higher prevalence of wheeze specifically, when 
compared with children of other races (10).  Considering race, non-Hispanic Black 
children have twice the prevalence of asthma compared to non-Hispanic White children 
and Hispanic children (58), especially among 3 to 10 years-olds (5).  The high rates of 
asthma prevalence among Blacks and Hispanics may not be due solely to race; these 
rates may be influenced by socioeconomic status as well, since a greater proportion of 
these races compared to other races tend to live in poverty (3).   
Dietary intake is also gaining interest as a risk factor for the development of 
asthma (6).  Inadequate intakes of a number of nutrients are thought to influence asthma, 
possibly by augmenting inflammation and bronchial hyperresponsiveness (48, 67).  In 
particular, low intakes of antioxidants and omega-3 fatty acids are thought to enhance 
wheezing (31).  Low intakes of fresh, unprocessed foods, especially fruits and 
vegetables, may be involved in a decline of lung function in children, which may result 
in an increase in asthma symptoms (31).  One study proposes that increasing the intake 
of fresh fruits and vegetables, especially those rich in vitamin C and other antioxidants, 
may protect against asthmatic inflammation (10).   
A handful of studies have suggested that intake of certain foods, including fresh 
fruits and vegetables, protects against asthma (10, 31, 67).  This is mainly due to the 
antioxidant effects of nutrients found in these foods, mainly vitamins A, C, and E (10, 
67).  Vitamin C is a major antioxidant that is present in the surface liquid of the lungs 
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(10, 67).  It works by scavenging superoxide radicals and inflammatory factors, such as 
PGF2-alpha, which contribute to bronchoconstriction (10).  Romieu et al. showed an 
association with vitamin C intake and a decrease in wheezing and an increase in lung 
function (10).  A study by Baker and Ayres also showed an association between vitamin 
C and improved lung function but not with a decrease in asthma symptoms (67).  
Research conducted at the Beltsville Human Nutrition Research Center, U.S. 
Department of Agriculture reports that the mean intake of vitamin C for boys and girls 
18 years and younger is above the DRI for vitamin C.  However, this may disguise 
variations among individuals.  For example, only 73% of the boys and girls in this age 
group were reported to be meeting the recommended dietary allowances (35).  Dietary 
supplements may be recommended in some cases, but should not replace food intake.  
However, research shows that the use of supplements, such as vitamins and minerals, in 
conjunction with prescribed therapeutic treatments is becoming more and more common, 
especially among patients with chronic illnesses (68).  The safety and efficacy of 
supplements is not well known, nor is it known whether supplements interact with 
prescription medications (4, 67).  It is recommended that nutrient needs be met through 
the consumption of healthful foods (4).  Healthful food sources of vitamin C, for 
example, include citrus fruit, strawberries, bell peppers, and broccoli (4).   
The prevalence of allergic diseases, such as rhinitis, may be influenced by fatty 
acid content of foods, mainly omega-6 and omega-3 fatty acids (49).  It is has been 
demonstrated that fat intake can change the composition of fatty acids in the body.  
Through this mechanism, dietary fat may influence eicosanoid production and therefore 
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may alter inflammatory response (36).   Eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) are long-chain omega-3 fatty acids found in shellfish and 
fish such as salmon and trout (4, 69).  They may also be synthesized in the body from 
dietary alpha-linolenic acid, an omega-3 fatty acid (36).  Omega-3 fatty acids suppress 
inflammation by inhibiting the mechanisms of eicosanoids, mainly leukotrienes, which 
are products of arachidonic acid (ARA) (36).  The effect of omega-3 fatty acids on ARA 
metabolism is similar to the mechanism of corticosteroids, which are most commonly 
used to treat asthma (36).  EPA inhibits the production of ARA, an omega-6 fatty acid, 
and inhibits the action of 5-lipoxygenase, the major enzyme in leukotriene synthesis 
(36).  Recommended intake of omega-3 fatty acids is 1.6 g/day for men, 1.1 g/day for 
women, and 0.5-1.2 g/day for children aged 0 to 13 years (36).  No studies have reported 
any adverse side effects as a result of omega-3 fatty acid supplementation (36).   
Obesity is becoming an increasingly important concern as a risk factor for 
asthma (3, 6, 10, 31).  It has been reported in some studies that increasing weight is 
associated with worse asthma control (32), and now we are beginning to see correlations 
between excess body weight and asthma onset as well.  Risk for asthma development has 
been reported to be higher in overweight children compared to children with a healthful 
body weight (33).  Several studies have shown that obesity, especially abdominal obesity 
(49), contributes to asthma prevalence, even after controlling for physical activity (31); 
although, this association may be weak when compared to other risk factors, such as 
allergy (70).   In children, overweight at birth or later in childhood contributes to the risk 
of future asthma (70).   
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Some studies have observed higher asthma prevalence rates, asthma 
hospitalization rates, and asthma mortality rates in boys compared with girls (64).  
Others have observed higher prevalence rates, hospitalization rates, and mortality rates 
in girls, particularly due to non-allergic asthma (33, 71).  These disparities may be the 
result of differences in airway anatomy or mechanics, hormones, or environmental 
exposures (31, 33, 64).  In general, rates of asthma are typically higher in boys during 
preadolescence, while in girls the rates are higher during adolescence (31, 64).  In adults, 
women are more likely to have non-allergic asthma (26) and asthma emergency 
department visits compared with men (15).  Factors possibly contributing to gender 
differences for asthma symptoms, asthma prevalence, and asthma severity include 
variations in hormones, exposure to allergens, airway caliber, and many lifestyle factors, 
including diet, activity level, or presence of obesity (7, 64, 72, 73).   
The severity of asthma prevalence is indicated by its inclusion in the Healthy 
People 2010 objectives (45).  The identification of risk factors for asthma and allergic 
diseases is important for the development of appropriate prevention and treatment plans 
(74).  Identification of these risk factors will help to alleviate disease morbidity and 
mortality (17, 41) and will help to identify individuals with asthma who have not yet 
been diagnosed (56).  Disease prevention and management is an important part of 
lowering the financial burden associated with chronic diseases (40, 59).  Identification of 
risk factors will also help to control the asthma epidemic in children (33).   
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Consequences 
Asthma is a major cause of morbidity and mortality in the U.S. (21, 75) despite 
advances in disease management (75), which contributes to a decline in quality of life 
and a rise in health care costs (36).  A survey based on the Behavioral Risk Factor 
Surveillance System reported that 30% of individuals had an unexpected visit to their 
physician for asthma, 30% experienced some level of activity limitation due to asthma, 
and more than 50% had sleep disturbances caused by asthma (76).  Asthma and its 
comorbidities, such as allergic rhinitis, are associated with greater asthma burden and 
higher health care costs compared to asthma alone (30).  Asthma is generally 
characterized by reversible airway obstruction; however, if asthma is persistent for 
extended periods of time, it may lead to irreversible airway obstruction (39). 
Asthma is responsible for more illness and disability in children than any other 
childhood disease (5).  Asthma may adversely impact playing, learning, and sleeping, 
which often requires specific interventions that result in increasing medical costs (2).  
Lenney reported that about one-third of asthmatic children experienced five or more 
asthma episodes in the previous 12 months, which contributed to a significant number of 
school absences, limitations in physical activity, and impaired functioning due to sleep 
disturbances (18).  Most notably, children of families that have difficulty complying 
with asthma management therapy, such as medication use, symptom monitoring, and 
avoidance of allergens, are likely to experience more frequent exacerbations, activity 
limitations, school absences, missed sleep, and functional, learning, and behavioral 
disabilities (63). 
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Asthma contributes to more school absences than any other chronic medical 
condition in childhood (17, 18).  Some asthma surveys report that as many as 40% of 
children miss school because of asthma (77), while others have reported a proportion as 
high as 60% (18).  Children with asthma miss more school days than children who do 
not have asthma (63).  Data suggest that students with asthma miss an average number 
of 10 days of school each year due to asthma symptoms (18).  A study by Akinbami 
reported that approximately 4 million children had an asthma attack in the previous year, 
which subsequently led to school absences (2). 
Having a chronic illness can be stressful, especially for children who may have 
trouble managing their disease at school (73).  Individuals with asthma commonly 
experience sleep disturbances, which may then affect physical and mental health.  
Interrupted sleep can cause irritability, aggression, inability to concentrate, and possible 
memory loss (40).  Children with a more severe form of asthma have more trouble 
adapting and incur more behavioral and academic problems (63). 
Both children with diagnosed asthma as well as those with undiagnosed asthma 
experience decreased quality of life as a result of their asthma (2, 60).  Children with 
diagnosed asthma tend to score lower on quality of life surveys than children with 
undiagnosed asthma, probably because children who are undiagnosed have a very mild 
form of asthma (60).  A decline in quality of life is usually exacerbated by frequent 
asthma symptoms, such as dyspnea during exercise, and comorbidities, such as rhinitis 
(78).  Studies show that up to two-thirds of individuals suffer from activity limitations 
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due to asthma (23).  The degree of limitation should be considered when instituting 
asthma therapy goals (23). 
Mortality 
Asthma has become an important cause of morbidity and mortality since 1980, 
and it continues to be a concern despite advances in understanding of the disease and its 
management (21, 75).  There are many factors that could potentially lead to death from 
asthma.  These include severe disease, poor disease control, and psychosocial problems 
(37).  Life threatening asthma exacerbations are of particular concern among children, 
and may be caused by a number of factors.  Parents may not recognize asthma symptoms 
in their children, or they may ignore them (22).  Children may not recognize their own 
symptoms, may deny them, or may choose not to seek medical attention (22).  Or, 
asthma control may be overestimated and the need for interventions may not be 
implemented, resulting in worsening asthma that could lead to death (76).  Poor 
adherence to therapeutic treatment of asthma also contributes to asthma morbidity and 
mortality (79).   
Asthma mortality increases with increasing severity, increasing medication use, 
and increasing age (37).  Asthma death rates increased steadily from 1980 to 1998 (2).  
In 2004, the asthma death rate among children was 2.5 deaths per 1 million children, for 
a total of 186 asthma deaths (2).  Asthma deaths among children under 15 years of age is 
relatively low, at 2% of all asthma deaths (18), while adolescents seem to be at greater 
risk for asthma death compared to younger children (2). 
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In 1980 chronic lower respiratory disease was the 5th leading cause of death 
among the American population, with 56,000 deaths reported.  In 2003, chronic lower 
respiratory disease increased to the 4th leading cause of death, with more than 126,000 
deaths reported.  In 1980, chronic lower respiratory disease was not a significant cause 
of death among children and adolescents.  In 2003, however, chronic lower respiratory 
disease was the 8th leading cause of death among 5 to 14 year-olds, and it was the 9th 
leading cause of death in 15 to 24 year-olds (5).   
Black children seem to be at greater risk for asthma death compared with White 
children, a disparity which continues to widen (2).  The higher prevalence of asthma 
morbidity seen among minority groups (3) and among those living in urban areas (24) is 
likely influenced by poverty or socioeconomic background.  Children who have severe 
asthma, uncontrolled asthma, a history of hospitalizations for asthma, or life-threatening 
episodes for asthma are at highest risk for asthma mortality (2).   
Health Care 
Health care utilization for asthma continues to rise.  Resources commonly 
utilized for disease care and management include hospitals, emergency departments, 
physician offices, and outpatient clinics.  The observed increase in health care use may 
be due to an increase in awareness and diagnosis of asthma, which may increase the 
likelihood that individuals will seek care for asthma symptoms.  It may also be due to 
increasing disease severity, which may warrant a higher number of health care visits (2).  
As asthma control worsens the number of visits to physician offices, hospitals, and 
emergency department increases (23, 80) as does the use of rescue medications (23). The 
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degree of health care utilization for asthma is a good indication of the level asthma 
control and management (30).  In addition to frequency of hospital and emergency 
department visits (24), medication use is also a good indicator of control, with the use 
more medication indicating worse asthma control (30).   
Compared to children with no asthma, asthmatic children use more health care 
resources. Children with a combination of asthma and rhinitis use more health care 
resources than children with asthma alone (30).  Although asthma prevalence increases 
with age, the youngest children use more health care resources for asthma than older 
children.  This may be due to a decline in asthma severity, increased asthma control, or 
lack of access to health care resources in older children (2).   
In 2002, asthma was one of the five leading causes of hospitalizations, along with 
other ambulatory care-sensitive medical conditions, including gastrointestinal disorders, 
pneumonia, and seizures (81).  These conditions continue to account for 36% of all 
hospitalizations (81).  Risks for asthma hospitalization include previous admission for 
asthma, previous intubation, and severe asthma symptoms (2).  Those with more severe 
disease, such as moderate to severe persistent, had fourfold higher hospitalization rates, 
twofold greater urgent visits, and fourfold greater risk of missing more than five days of 
work due to asthma compared to individuals with a mild form of asthma (23).   
Asthma is the leading cause of hospitalization in childhood (22).  In 2003, there 
were 132,000 hospitalizations, 475,000 emergency department visits, and 4.6 million 
visits to physician offices or outpatient clinics for asthma among children 3 to 17 years 
of age (5).  Race may play a role, as Black children, compared with White children, have 
 30 
a 250% higher hospitalization rate, a 260% higher emergency department visit rate, and 
a 500% higher death rate due to asthma, and this disparity continues to widen (2).  In 
2004, the rate of hospitalization due to asthma was 27 hospitalizations per 10,000 
children, for a total of 198,000 hospitalizations (2).  The rise in hospitalizations may be 
influenced by diagnosis of asthma (2), asthma severity, access to health care resources, 
or compliance with disease management therapy (64).  
In 2004, the rate of emergency department visits for asthma was 103 visits per 
10,000 children, for a total of 750,000 visits.  For children under 18 years of age, visits 
to the emergency department represent about 2.8% of all emergency department visits 
for this age group (2).  Asthma exacerbations that require the emergency department 
may indicate severe asthma, uncontrolled asthma, inadequate access to a respiratory 
specialist, or inappropriate use of the emergency department (2).  Recurrent visits to the 
emergency department may be a risk factor for adverse outcomes including death (2). 
Cost 
In 1990, health care costs attributed to asthma in the U.S. exceeded $6.2 billion.  
Most recent estimates report asthma-related health care costs in the U.S. to be 
approximately $11 billion.  The increasing morbidity and mortality associated with 
asthma has played a role in the rising costs (7).  The main factors contributing to asthma-
related health care costs are hospitalizations and medications (18).   
As the number of symptoms increases, so does the cost associated with primary 
care and secondary care utilization.  An increase in symptoms is also associated with an 
increase in the costs associated with prescription medications, both in individuals with 
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diagnosed and undiagnosed asthma (82).  Although, children with an asthma diagnosis 
tend to incur higher health care costs than children without a diagnosis of asthma, failure 
to include these undiagnosed children in the process of estimating asthma-related health 
care costs, will underestimate the true cost associated with treating asthmatic children 
(82).  As asthma control worsens, health care costs have a tendency to rise.  It is reported 
that health care costs may be more than twofold greater for individuals with uncontrolled 
asthma compared with individuals whose asthma is under total control (80).   
Asthma Among the Overweight and Obese 
Prevalence 
Both asthma and obesity have increased at similar rates over the past two 
decades, suggesting a possible relationship between the two (10, 70).  In many countries, 
there has been a greater increase of obesity in adults with asthma compared with those 
without asthma (48).  Estimates report that a higher proportion of children in the 85th 
percentile or above for BMI developed asthma compared to children below the 85th 
percentile (13, 21).  This suggests that excess weight increases the risk of asthma.  Yet, 
others report no significant associations between BMI and asthma in children (33). 
An association has been reported between high BMI and asthma prevalence 
independent of age, gender, birth weight, breast feeding, passive exposure to smoke, 
socioeconomic status, and exercise (31).  In general, this rise is also independent of 
leisure time activity in men and women (46).  In addition to asthma prevalence, research 
also shows an association between increasing BMI and the lifetime prevalence of 
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wheeze, previous 12-month wheeze, exercise-induced wheeze, asthma diagnosis, asthma 
treatment, and airway hyperresponsiveness (31).   
Research shows that there may be increased asthma risk especially with 
increasing abdominal obesity (49).  A threshold weight level for which the risk of 
asthma increases has not been indicated, though (70).  It has been suggested that obesity 
has a greater effect on non-allergic asthma than allergic asthma (26, 33). Many studies 
report a higher prevalence of obesity among non-allergic asthmatics compared with 
allergic asthmatics, suggesting no association between obesity and atopy (26, 33, 49).  
This is often supported by measuring circulating levels of immune factors, such as IgE.  
Chen et al. showed no correlation between BMI and hay fever; nasal allergies; IgE levels 
for dust mite, grass, or cat dander; or total IgE levels, suggesting no involvement of 
atopy in the obesity-asthma association (26).  Individuals with allergic asthma are more 
likely to be children, so evidence suggests that the association between BMI and asthma 
in these individuals is weak (26).  While the absence of immune factors seems to suggest 
that BMI is not associated with asthma through an allergic pathway, it may be that BMI 
may have different effects on individuals with allergic asthma compared with those with 
non-allergic asthma (26).   
Many studies report gender differences in the risk of asthma with overweight.  In 
a study by Gold et al., both overweight girls and girls with the largest annual increases in 
BMI had a greater risk of asthma onset compared with girls with lower BMIs (7).  This 
same study also reported that both boys with the highest annual increases and boys with 
the lowest annual increases in BMI were at greater risk of asthma onset (7).  Other 
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studies report an increased risk of asthma in overweight boys but not in overweight girls 
(31, 33).  The differences reported in these studies may suggest that there is a vulnerable 
age for boys and for girls during which overweight increases asthma risk (21).  
Schachter et al. reported associations between high BMI and a higher prevalence of 
atopy, wheeze in the last 12 months, wheeze ever, cough, and medication use in girls but 
not in boys; however, no association was reported between high BMI and asthma 
prevalence for either gender, indicating possible changes in mechanical function that 
could lead to asthma-like symptoms (34).  In contrast, another study did report an 
association between high BMI and asthma prevalence, but this was observed to higher 
degree in boys than in girls (21).   
 Similar to the findings in children, gender differences have also been reported in 
the association between obesity and asthma in adults.  Chen et al. reported a 6% increase 
in asthma risk for every one unit increase in BMI in women.  Conversely, men only 
experienced a 3% increase in asthma risk with every one unit increase in BMI (26).  So, 
while both men and women experienced an increase in asthma risk with increasing BMI, 
the effect was more pronounced in women (26).  Adiposity, as measured by body fat 
percentage, was related to current asthma in women.  In men, adiposity, whether 
measured by body fat percentage or BMI, was not related to asthma (47).  The risk of 
asthma is twice as great among overweight or obese women compared to women with a 
healthful body weight (46).  In men, increasing BMI was clearly related to asthma, but 
not clearly so with wheezing, allergic rhinitis, conjunctivitis, or atopic dermatitis (46).  
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Conversely, in women, increasing BMI was related to wheezing, allergic rhinitis, and 
conjunctivitis (46). 
Obesity is commonly associated with symptoms of asthma including bronchial 
hyperresponsiveness (41), lifetime wheeze, previous 12-month wheeze, and exercise-
induced wheeze (31).  BHR (31), low pulmonary volumes, and low thoracic wall 
expansion have been shown to be more common in obese children compared with 
children who are not obese (10).  Obese children are also more likely to suffer from 
coughing, wheezing, dyspnea (10, 34), shortness of breath (33), and a greater number of 
symptom-days than non-obese children (48).  Adult asthmatics who were obese reported 
more symptoms, a greater number of symptom-days, greater activity limitations, and 
greater medication use (1).    
Some studies suggest that BMI is associated with symptoms of asthma and not 
with asthma itself (34, 83).  Many obese individuals exhibit a higher frequency of 
respiratory symptoms, such as dyspnea, especially on exertion and tend to report more 
bronchodilator use, yet they often show less frequent airway obstruction compared with 
non-obese asthmatics.  This suggests that these obese individual may just be suffering 
from asthma-like symptoms, and may have been falsely diagnosed with asthma and are 
being treated inappropriately (48).  Another possible reason for a lack of association 
between BMI and asthma is that asthma may be underdiagnosed by physicians who 
inaccurately attribute asthma-like symptoms in overweight children to a lack of physical 
fitness when the child actually has asthma.  Other reports, however, do show an 
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association between BMI and physician diagnosis of asthma, regardless of atopy, family 
history of asthma, and exposure to cigarette smoke (34).   
Obesity seems to be more prevalent among asthmatics with poor control (53).  
One study shows an association between high BMI and poor asthma control independent 
of age, gender, and asthma severity (1).  Children with BMI’s in the 85th percentile or 
greater tend to have greater asthma severity (3) and worse asthma control (39).  This is 
often measured by number of missed school days, lung function tests, and number of 
prescribed medications (3).  Obesity also seems to hinder the transition from 
unacceptable asthma control to an acceptable state in both adults and children, even 
despite optimal pharmacological management (32).   
 While there may be an association between asthma control and excess weight, 
findings regarding an association between excess weight and asthma severity are 
inconsistent (1, 15).  In a study by Thomson et al., asthma exacerbations were similar in 
non-obese asthmatics compared with those who were obese (15), suggesting no 
difference in asthma severity.  While in a study by Lavoie et al., adult asthmatics who 
were obese reported more symptoms, a greater number of symptom-days, greater 
activity limitations, and greater medication use (1), indicating a greater asthma severity 
compared with those who were not obese (14).  Overall, asthmatics with excess weight 
experience worse asthma control, more limitations in daily activities, and a greater 
number of symptoms.  All of these factors contribute to a decline in quality of life in 
obese asthmatics, compared with non-obese asthmatics (1).   
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Relationship Between Asthma and Obesity 
The association between obesity and asthma may be due to many factors 
including diet, physical activity, hormones, immune factors, and mechanical factors (31).  
Body fat is believed to impart excess mechanical load on the airways resulting in 
hyperresponsiveness.  It is also believed to release inflammatory factors which may 
affect breathing (33, 53).  Also, because of anatomical differences in the airways of 
children and adults, it is believed that excess body weight may have different effects on 
breathing in children and adults (34). 
Adipose tissue is known to release factors that have an effect on most parts of the 
body.  Obesity is considered to be an inflammatory disorder because adipose tissue 
releases substances, such as leptin, that stimulate the production and release of 
inflammatory factors, including IL-6, TNF-alpha, C-reactive protein, and chemokines (6, 
33, 39).  Thus, it is believed that obesity may be associated with asthma through an 
inflammatory mechanism (6, 32, 33, 38-40, 47, 49, 53).  The release of inflammatory 
factors adversely affects the respiratory system (19, 40), which leads to the development 
of asthma. 
A study conducted by McLachlan et al. shows no association between body fat 
and airway inflammation (47).  In contrast, research conducted by Dixon et al. does 
show an association between body fat and airway inflammation (53).  Serum levels of 
inflammatory markers have been reported in obese asthmatics (53).  An association 
between asthma and obesity has been reported when a measure of waist circumference 
was used to define obesity (49).  If the nature of the association between obesity and 
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asthma is through a common inflammatory mechanism, Kronander et al. suggest that it 
may be better to measure waist circumference rather than BMI (49). 
In general, obese individuals breathe at a higher frequency but at lower tidal 
volumes than individuals who are not obese (6).  Central obesity has been shown to lead 
to a decrease in chest wall compliance and diaphragm movement (19, 47).  Decreased 
movement of the diaphragm leads to less compression on the thorax, less stretching of 
the bronchial muscles, and a decrease in tidal volume (49).  The increased load on the 
chest in combination with the decreased work of respiratory muscles results in increased 
work of breathing (19, 39, 47).  Increased demand on respiration and a decline in lung 
function result in airway hyperresponsiveness in obese individuals (19, 39, 49, 53).  
These changes in lung function result in increased risk of wheeze, shortness of breath, 
and other asthma-like symptoms (26).  A decline in lung function imposed by this 
mechanical load includes a decrease in forced expiratory volume (FEV), forced vital 
capacity (FVC), total lung capacity, functional residual capacity, and expiratory reserve 
volume (39).  This leads to breathlessness and other asthma symptoms (26), which is 
particularly evident during exercise (40).  Some studies report an association of adiposity 
with FEV/FVC ratio but not with airway inflammation.  This supports the suggestion 
that excess weight leads to airway obstruction due to a mechanical mechanism rather 
than an inflammatory mechanism (47).   
It has been reported that a larger proportion of women than men suffer from 
asthma, leading to the hypothesis that female sex hormones may play a role in this 
disparity (11).  This is of particular concern in obesity, because there is an enhanced 
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conversion of testosterone to estrogen by adipose tissue, resulting in an increased risk of 
asthma (39).  Estrogen may enhance cytokine profiles in obese individuals, especially 
women, which would enhance the inflammatory mechanism of obesity on asthma (46).  
Obesity is also believed to result in reduced progesterone levels.  This would in turn lead 
to a reduction in beta-2 receptor function and therefore a reduction in bronchial smooth 
muscle relaxation (26).  This is also supported by the observation that asthmatic women 
experience increased symptoms and decreased pulmonary function during the menstrual 
cycle when estrogen levels are at their peak (41).  Post-menopausal women experience 
less bronchial hyperresponsiveness compared with pre-menopausal women; however, 
bronchial hyperresponsiveness increases in post-menopausal women who are being 
treated with estrogen replacement therapy (41). 
There is some evidence that diet may play a role in the association between 
obesity and asthma (11, 33).  Overweight and obese individuals tend to consume diets 
high in calories and low in important micronutrients (10).  Some researchers have 
identified specific components of the diet that may play a direct role in this association, 
particularly vitamin C and omega-3 fatty acids, as were mentioned earlier in this chapter 
(49, 70).  Research on the association between fruit and vegetable intake on overweight 
among children is limited (84); however, one study did find that overweight children and 
adults consumed fewer fruits than healthy weight children and adults.  The correlation 
between vegetable consumption and weight status was found to be significant only 
among adults, though (85).  Finally, obese individuals generally have high levels of 
comorbidities, which may play a role in the association between obesity and asthma.  
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For example, obese individuals have a higher occurrence of gastroesophageal reflux 
disease (GERD), which has been identified as a risk factor for asthma (19, 29, 53, 70).  It 
has been reported that 45% to 65% of asthmatic children and adults also suffer from 
GERD (29).   
Some have suggested that obesity is a consequence of asthma rather than a cause.  
Individuals with asthma that is poorly controlled may be prone to adopt a sedentary 
lifestyle that then leads to weight gain (9, 38, 46, 49).  Another mechanism may be that 
individuals with asthma may be taking medications, mainly corticosteroids, which may 
lead to weight gain (48). 
Consequences 
Obese asthmatics suffer from comorbidities commonly associated with asthma, 
such as rhinitis and sinusitis, to a similar extent as non-obese asthmatics (53).  
Additionally, they tend to suffer more from GERD and sleep disturbances compared to 
non-obese asthmatics (53).  GERD, as mentioned previously, is believed to be a risk 
factor for asthma.  Therefore, obese individuals are at greater risk for asthma and 
asthma-like symptoms (53).  Obesity is also a risk factor for obstructive sleep apnea as 
well as other respiratory problems (19, 40).  Obstructive sleep apnea is characterized by 
a partial or complete obstruction of the airways that leads to hypoxia, then to arousal and 
sleep disturbance.  This often is the cause of daytime sleepiness, irritability, aggression, 
impaired concentration, and a lower quality of life (19).  In children, it may result in 
impairment of school function, learning, and memory (13).   
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Adult asthmatics with obesity reported more symptoms, a greater number of 
symptom-days, greater activity limitations, and greater medication use (1), indicating a 
greater asthma severity compared with those who were not obese (14).  Likewise, being 
overweight was associated with worse asthma severity and asthma control in children.  
Because overweight in children has been associated with poor asthma control, it is 
feared that this may lead to an increase in the number of young adults with severe 
asthma (39). 
A study by Van Gent et al. suggests that asthma with excess body weight results 
in a lower quality of life than asthma alone or excess body weight alone.  Based on the 
effect of asthma alone and excess body weight alone on quality of life, it was expected 
that asthma with excess body weight would result in a 15% lower score on quality of 
life.  However, the combined effect was a 25% lower score, proving to be the lowest 
quality of life of all the groups of children (38).  Measures of quality of life provide 
insight into functional impairment in the patient’s daily life (38).  Men typically 
experience a sharper decline in quality of life compared to women.  This is likely 
because men tend to be more active than women, therefore, loss of the capacity to 
perform certain activities may be more meaningful in men (1). 
Overall, obese asthmatics suffer more symptoms, use more medications, and visit 
the hospital and emergency department more frequently than non-obese asthmatics (1, 
15, 48, 86).  As much as 75% of asthmatics visiting the emergency department for 
asthma symptoms may be obese (15).  Obese asthmatics tend to use more rescue 
medications than non-obese asthmatics, most likely indicating worse asthma control 
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(53).  Compared with non-obese children, obese children who also have asthma are more 
likely to be treated with oral corticosteroids (38, 48) or inhaled corticosteroids (38). In 
general, obese asthmatics are reported to use high-dose corticosteroids (65) and long-
acting bronchodilators more frequently than those who are not obese (1).  They are also 
more likely to be taking a combination of two or more medications to treat their asthma 
(38, 48, 86). 
Summary 
Many researchers agree that evidence leans toward excess body weight as a risk 
factor for the onset of asthma (14, 31, 38, 48, 49).  Some argue that because obesity is 
associated with asthma severity independent of possible confounders, it is therefore a 
potentially modifiable risk factor for asthma (14).  The observation that weight reduction 
in obese asthmatics results in improvement of respiratory symptoms and improves lung 
function also supports the hypothesis that obesity is a risk factor for asthma (14, 38, 40, 
49).  Multiple studies reported a positive association between BMI and asthma 
development.  The development of asthma followed the development of obesity in these 
studies, which supports the hypothesis that excess body weight is a risk factor for asthma 
(48).  It may be that preconditions for asthma exist in certain individuals before the age 
of 6 years, and increasing BMI after this age further enhances the risk of developing 
asthma symptoms (7). 
Despite the research that has been conducted, there is still disagreement on the 
existence of a causal link between obesity and asthma (7, 14, 39, 40, 83, 86).  There are 
those who suggest that there is no association between obesity and asthma or airway 
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hyperresponsiveness (34), and then there are others who hypothesize that asthma is a 
risk factor for obesity in children, adolescents, and adults (3, 14, 48).  This may be 
supported by the observation that asthmatics tend to adopt a sedentary lifestyle in order 
to avoid exacerbations, therefore they are prone to gain weight (14).  Others suggest that 
weight gain develops as a side effect of corticosteroid therapy (48), a regimen commonly 
used to treat asthma. 
In many cases, it cannot be determined whether obesity or asthma occurred first 
(7), mostly due to the nature of the study design (39, 86).  It is difficult to determine the 
sequence of onset of asthma and obesity in cross-sectional studies (9, 10, 31, 41).  Data 
regarding the relationship between excess body weight and asthma in children are 
limited (38, 77), and the results of those studies that have been conducted on the 
relationship between asthma or asthma symptoms and obesity are often inconsistent (10, 
11).   
As mentioned in the previous chapter, it is the objective of this thesis to analyze 
the relationship between asthma and obesity in pre-adolescent and adolescent children.  
Asthma diagnosis will be compared with measures of obesity, allergy diagnosis, dietary 
vitamin C and omega-3 fatty acid intake, vitamin C and omega-3 fatty acid supplement 
use, ethnicity, with whom the child lives, mother’s education, and whether the mother 
smokes.  The use of prescription asthma medication and prescription allergy medication 
will be compared with the presence of asthma and allergies, as well as with measures of 
obesity. 
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CHAPTER III 
METHODS 
 
This chapter will describe the data and methods used to collect the data in more 
detail.  The data used in this analysis were derived from the Parental Time, Role Strains, 
Coping, and Children’s Diet and Nutrition project conducted by Texas A&M University 
between July 2001 and June 2002, with permission by the authors.  The complete data 
set is quite extensive and was not used in its entirety.  Instead, variables of interest for 
this analysis were selected from the data set.  The resulting sample and its variables are 
described in more detail later in this chapter.  Analysis was conducted on asthma 
prevalence, overweight prevalence, and the association between the two in males and 
females between the ages of 9 and 11 years and between 13 and 15 years.  Statistical 
analysis was conducted using SPSS statistical software.  Tests used in the analysis of the 
sample are discussed at the end of this chapter.   
Data 
A random sample of approximately 300 households in the Houston Metropolitan 
Statistical Area, an area with a high concentration of ethnic groups, was generated by 
random digit dialing.  A randomly generated sample of more than 10,000 phone numbers 
was obtained from Survey Sampling, Inc.  Unassigned, disconnected, and non-household 
phone numbers had been removed from the sample.  A 50% contact rate, 50% 
cooperation rate, and 50% completion rate were assumed when determining sample size.  
The project was designed to include households with a child between the ages of 9 and 
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11 years or between 13 and 15 years.  To avoid difficulties with self-reporting data, 
children younger than 9 years were excluded.  Because children often undergo puberty at 
age 12 (43), children of this age were also excluded in order to create a sample of pre-
pubertal and post-pubertal children.  Data were collected in the form of a telephone 
interview of each parent, a self-administered questionnaire of each parent, a personal 
child interview, a 24-hour child diet recall, and a child two-day diet diary.  The interview 
and questionnaire were identical for each parent and the child’s interview mimicked the 
parent interview.  The 24-hour diet recall for the day prior to the interview was obtained 
through a multiple-pass method.  A two-dimensional booklet containing photographs of 
specific foods was used to help determine portion sizes (87).  The booklet was retained 
by the children to aid in the two-day diary.  Information regarding the two-day diet diary 
was obtained by the interviewer over the telephone.  Dietary intakes for the three days 
were analyzed with the Food Processor program to obtain nutrient intakes for each day 
(88).  A brief physical exam was administered to children to obtain body composition 
measurements.  Anthropometric measurements, including height, weight, waist 
circumference, hip circumference, triceps skinfold thickness, and subscapular skinfold 
thickness, were obtained according to procedures established by Lohman et al (89).  
Interviewers were trained to take body composition measurements and were not allowed 
to examine the children until they could obtain three consecutive measures within one 
centimeter of each other.  Children were asked to wear lightweight, loose-fitting clothes 
and were asked to remove their shoes to obtain height and weight.  Height was measured 
to the nearest 1/8 inch using a non-stretch metal tape and a metal triangle.  Weight was 
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measured to the nearest 0.5 pound using a 12 inch by 12 inch 500 pound parcel scale. 
Waist circumference was measured to the nearest 0.1 cm using a flexible nylon tape 
measure.  The measurement was taken at the narrowest section below the rib cage and 
above the navel.  Hip circumference was taken while the child was standing.  Three 
triceps and three subscapular skinfold measurements were taken on the right side of the 
body to the nearest millimeter using a skinfold caliper.  The average of the three 
measures was used for analysis.   
The parent telephone interview and self-administered questionnaire were 
designed to gather information regarding employment, parenting style, concern about 
children’s eating habits, parental health, children’s health, and demographics and 
sociological information, economic information, and time use, respectively.  The child 
interview was designed to gather information on child’s relationships with parents, 
parenting style, child’s health, self-esteem, family meal rituals, children’s work, dietary 
behavior, activity level, and demographics.  Data were collected from more than 300 
families, including mothers, fathers (if present), and one child.  The final data set 
consisted of over 2000 variables for each family.  
Variables 
For this thesis project, the variables of interest for the child included dietary 
vitamin C intake, dietary omega-3 fatty acid intake, supplement usage, including the use 
of multi-vitamin/mineral supplements, omega-3 fatty acid supplements, and vitamin C 
supplements; vitamin C and omega-3 fatty acid dietary intake; ethnicity; gender; age; 
height; weight; waist circumference; hip circumference; triceps skinfold thickness; 
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subscapular skinfold thickness; composition of household; allergy diagnosis; allergy 
medication use; asthma diagnosis; and asthma medication use.  The variables of interest 
for the parents included smoking habit, weight, height, and education completed.  If the 
subject could not be categorized by age or gender, the case was thrown out.  Only cases 
in which the subject was between the ages of 9 and 11 years or 13 and 15 years were 
retained for analysis.  Because fathers were not always present, because many responses 
from fathers were missing, and because parents completed identical interviews and 
questionnaires, only responses from mothers were retained for analysis.  The resulting 
sample contained 303 cases and 31 variables. 
 The parent variables of interest were obtained from the parent interview.  
MOMWT was a continuous variable that represented the weight of the mother in 
pounds.  It was labeled as ‘mother weight (lbs)’ and was derived from the response to 
the question, “How much do you weight?”  MOMHT was a continuous variable that 
represented the height of the mother in inches.  It was labeled as ‘mother height (in)’ and 
was derived from the response to the question, “How tall are you?”  MOMBMI was a 
continuous variable that represented the mother’s BMI.  It was labeled as ‘mother BMI’ 
and was calculated from the variables MOMWT and MOMHT.  MOMBMICAT was a 
categorical variable that represented the mother’s BMI category.  It was determined by 
categorizing MOMBMI into the following categories according to the CDC: 
underweight, normal weight, overweight, or obese.  MOMSMK was a categorical 
variable that represented whether the mother smokes.  It was labeled as ‘mother smokes’ 
and was derived from the response to the question, “Do you smoke cigarettes?”  
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Responses included yes or no.  MOMEDU was a categorical variable that represented 
the level of education completed by the mother.  It was labeled as ‘mother level of 
education’ and was derived from the response to the question, “How much education 
have you completed?”  Optional responses ranged from ‘some grammar school’ to 
‘completed graduate school’. 
 Child variables regarding diagnosed medical conditions and prescription 
medication usage were also obtained from the parent interview.  ALLERGIES was a 
categorical variable that represented the diagnosis of the child with allergies.  It was 
labeled as ‘diagnosed with allergies’ and was derived from the response to the question, 
“Has your child ever been diagnosed with the following conditions?”  Optional 
responses included asthma, diabetes, heart disease, high blood cholesterol, eating 
disorder, attention deficit hyperactivity disorder, and other.  ASTHMA was a categorical 
variable that represented a diagnosis of the child with asthma.  It was labeled as 
‘diagnosed with asthma’ and was derived from the response to the same question asked 
for the diagnosis of allergies.  ALLRX and ASTHRX were categorical variables derived 
from the question, “Why was it prescribed?” following a ‘yes’ response to the previous 
question.  ALLRX represented the use a medication for allergies and was labeled as 
‘taking allergy prescription’.  ASTHRX represented the use of a medication for asthma 
and was labeled as ‘taking asthma prescription’.  If the medication was reported to be 
taken for allergies, a ‘yes’ response was marked for ALLRX and the remaining 
responses for that variable were marked as ‘no’.  If the medication was reported to be 
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taken for asthma, a ‘yes’ response was marked for ASTHRX and the remaining 
responses for that variable were marked as ‘no’.   
 Child variables were also obtained from the child interview.  GUARDIAN was a 
categorical variable that represents with whom the child lives.  It was labeled as ‘with 
whom child lives’ and was derived from the response to the question, “Do you live with 
your real or biological mom and dad, other relatives, or with step-parents?”  Optional 
responses included with real (biological) mom and dad, with biological mom only (no 
other parent), with biological mom and step-dad, with real dad and step-mom, with 
biological mom and other relatives, or with adoptive or foster parents.  Given than a vast 
majority of responses that consisted of ‘biological mom and dad’, alternative responses 
were collapsed into a single category labeled as ‘other’.  AGE was a continuous variable 
that represented the age of the child in years.  It was labeled as ‘age (yrs)’ and was 
derived from the response to the question, “How old are you?”  ETHNICITY was a 
categorical variable the represented the ethnic background of the child.  It was labeled as 
‘ethnic background’ and was derived from the response to the question, “What is your 
ethnic background?”  Optional responses included Hispanic, Black, White, or other.  
Given the numerous responses of White ethnicity, responses other than White were 
collapsed into a single category labeled as ‘other’.  GENDER was a categorical variable 
that represented the gender of the child.  It was labeled as ‘gender’ and was determined 
by the interviewer as male or female.   
OMEGA, VITC, and MULTI were categorical variables that were derived from 
the response to the question, “During the past month, have you taken supplements in pill, 
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liquid, or powder form?”  Children were allowed to choose from an extensive list of 
supplements and were given the opportunity to report any supplements not on the list.  
OMEGA represented the use of an omega-3 fatty acid supplement by the child and was 
labeled as ‘omega-3 fatty acid supplement’.  If a child reported using an omega-3 fatty 
acid supplement, then a ‘yes’ response was marked for this variable.  If no use of this 
supplement was reported, a ‘no’ response was marked for this variable.  VITC 
represented the use of a vitamin C supplement and was labeled as ‘vitamin C 
supplement’.  If a child reported using a vitamin C supplement, then a ‘yes’ response 
was marked for this variable.  If no use of this supplement was reported, a ‘no’ response 
was marked for this variable.  MULTI represented the use of a multi vitamin/mineral 
supplement by the child and was labeled as ‘multi vitamin/mineral supplement’.  
Reported supplementation with a multiple vitamin and/or a multiple vitamin/multiple 
mineral by the child was combined into one variable, MULTI, and was marked as a ‘yes’ 
response for this variable.  If no use of either type of supplement was reported, a ‘no’ 
response was marked for MULTI.   
Child anthropometric variables were obtained by the interviewer during an 
anthropometric assessment.  HEIGHT was a continuous variable that represented the 
height of the child in inches.  It was labeled as ‘height (in)’ and was measured to the 
nearest 1/8 inch without shoes and without leaning against a wall.  WEIGHT was a 
continuous variable that represented the weight of the child in pounds.  It was labeled as 
‘weight (lbs)’ and was measured to the nearest half pound without shoes.  BMI was a 
continuous variable that represented the child’s BMI.  It was labeled as ‘BMI’ and was 
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calculated from the variables WEIGHT and HEIGHT.  BMIPER was a continuous 
variable that represented the child’s BMI percentile.  It was labeled as ‘BMI percentile’ 
and was determined using the variable BMI and the CDC growth curves.  BMICAT was 
a categorical variable that represented the child’s BMI percentile category.  It was 
labeled as ‘BMI percentile category’ and was determined by categorizing BMIPER into 
the following categories according to the CDC: underweight, healthy weight, at risk for 
overweight, or overweight.  WAIST was a categorical variable that represented the waist 
circumference of the child in centimeters.  It was labeled ‘waist circumference (cm)’.  
Measurements were then categorized into the following ranges for analysis: less then 
50.0 cm, 50.0 cm to 59.9 cm, 60.0 cm to 69.9 cm, 70.0 cm to 79.9 cm, 80.0 cm to 89.9 
cm, 90.0 cm to 99.9 cm, or 100.0 cm or more.  HIP was a categorical variable that 
represented the hip circumference of the child in centimeters.  It was labeled as ‘hip 
circumference (cm)’.  Measurements were then categorized into the following ranges for 
analysis: less than 50.0 cm, 50.0 cm to 59.9 cm, 60.0 cm to 69.9 cm, 70.0 cm to 79.9 cm, 
80.0 cm to 89.9 cm, 90.0 cm to 99.9 cm, or 100.0 cm or more.  WAISTHIP was a 
categorical variable that represented the waist/hip ratio of the child.  It was labeled as 
‘waist/hip ratio’ and was calculated from the variables WAIST and HIP then was 
categorized into the following ranges for analysis: less than 0.70, 0.70 to 0.74, 0.75 to 
0.79, 0.80 to 0.84, 0.85 to 0.89, 0.90 to 0.94, 0.95 to 0.99, 1.00 to 1.99, or 2.00 to 2.99.   
TRICEPS was a categorical variable that represented the triceps skinfold thickness of the 
child in millimeters.  Three measurements were taken and averaged.  The result was then 
categorized into the following ranges for analysis: less than 5.00 mm, 5.00 mm to 9.99 
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mm, 10.00 mm to 14.99 mm, 15.00 mm to 19.99 mm, 20.00 mm to 24.99 mm, 25.00 
mm to 29.99 mm, 30.00 mm to 34.99 mm, 35.00 mm to 39.99 mm, 40.00 mm or more.  
SUBSCAP was a categorical variable that represented the subscapular skinfold thickness 
of the child in millimeters.  Three measurements were taken and averaged.  The result 
was then categorized into the following ranges for analysis: less than 5.00 mm, 5.00 mm 
to 9.99 mm, 10.00 mm to 14.99 mm, 15.00 mm to 19.99 mm, 20.00 mm to 24.99 mm, 
25.00 mm to 29.99 mm, 30.00 mm to 34.99 mm, 35.00 mm to 39.99 mm, 40.00 mm or 
more.   
 OMEGAINTAKE was a continuous variable that represented dietary intake of 
omega-3 fatty acids in grams by the child.  It was labeled as ‘omega-3 fatty acid intake 
(g)’ and was determined using the child’s 24-hour diet recall and 2-day food diary.  
VITCINTAKE was a continuous variable that represented dietary intake of vitamin C in 
milligrams by the child.  It was labeled as ‘vitamin C intake (mg)’ and was determined 
using the child’s 24-hour diet recall and 2-day food diary.  MEETOMEGA was a 
categorical variable that represented whether the child’s dietary intake met the AI for 
omega-3 fatty acids.  It was labeled as ‘meeting omega-3 fatty acid AI’ and was 
determined using the DRI tables provided by the USDA (90).  Responses consisted of 
‘yes’ if the child’s intake met the omega-3 fatty acid AI or ‘no’ if it did not.  
MEETVITC was a categorical variable that represented whether the child’s dietary 
intake met the DRI for vitamin C.  It was labeled as ‘meeting vitamin C DRI’ and was 
determined using the DRI tables provided by the USDA (90).  Responses consisted of 
‘yes’ if the child’s intake met the vitamin C DRI or ‘no’ if it did not. 
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Analysis 
Dependent variables were dichotomous, and included allergy diagnosis, asthma 
diagnosis, and prescription medication use.  Therefore binary regression analysis was 
used to analyze the relationship between these variables and measures of overweight, 
asthma/allergy diagnosis, ethnicity, guardian, household salary, mother’s education, and 
mother’s smoking habit.  All analyses were conducted using SPSS statistical software 
and were controlled for age and gender.  The Wald statistic was used to determine the 
presence of a relationship between dependent and independent variables.  Odds ratios 
provided insight into whether an existing correlation between the dependent and 
independent variables was a positive or inverse correlation.  All tests were analyzed 
using a significance level of p<0.05. 
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CHAPTER IV 
RESULTS 
 
This chapter will discuss variable frequencies and percentages and binary 
regression analysis.  All analyses were performed on the sample that was described in 
the previous chapter, the pre-adolescent sample, the adolescent sample, males, and 
females.  Different sample sizes for each variable represent different response rates.  
Tests of significance were measured at p<0.05.  The results of analyses are represented 
by tables throughout the chapter, which contain significant findings only. 
Frequency Distributions 
The entire sample was comprised of 303 subjects, roughly half male and half 
female.  The sample can also be divided by age group, containing approximately half 
pre-adolescent children and half adolescent children (Table 1).  The male and female 
samples showed a similar age distribution with 52.9% pre-adolescents and 47.1% 
adolescents for males and 53.4% pre-adolescents and 46.6% adolescents for females.  
The mean age of the sample was 11.94 ± 2.168 years (Table 1).  The pre-adolescent 
sample, which was composed of children that have not yet entered into adolescence, is 
comprised of 9, 10, and 11 year-olds.  The mean age of this sample was 10.06 ± 0.808 
years.  The adolescent sample, composed of children who have already entered into 
adolescence, included 13, 14, and 15 year-olds.  The mean age for this sample was 14.08 
± 0.803 years.  The mean ages of males and females were similar at 12.00 ± 2.144 years 
and 11.89 ± 2.199 years, respectively.  The ethnic distribution of the entire sample was 
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TABLE 1  Frequency (%) distributions for demographic variables. 
 
 
Gender 
Entire 
Sample 
Pre-Adolescents 
(9-11 years) 
Adolescents 
(13-15 years) 
Male Female 
N 303 161 142 155 148 
1 = Male 155 (51.2) 82 (50.9) 73 (51.4) 155 (100) 0 
2 = Female 148 (48.8) 79 (49.1) 69 (48.6) 0 148 (100) 
Age      
N 303 161 142 155 148 
9 48 (15.8) 48 (29.8) 0 19 (12.3) 29 (19.6) 
10 56 (18.5) 56 (34.8) 0 34 (21.9) 22 (14.9) 
11 57 (18.8) 57 (35.4) 0 29 (18.7) 28 (18.9) 
13 40 (13.2) 0 40 (28.2) 20 (12.9) 20 (13.5) 
14 50 (16.5) 0 50 (35.2) 25 (16.1) 25 (16.9) 
15 52 (17.2) 0 52 (36.6) 28 (18.1) 24 (16.2) 
Ethnicity      
N 301 159 142 154 147 
1 = White 217 (72.1) 117 (73.6) 100 (70.4) 108 (70.1) 109 (74.1) 
2 = Other 84 (27.9) 42 (26.4) 42 (29.6) 46 (29.9) 38 (25.9) 
Guardian      
N 294 157 137 151 143 
1 = Biological 
mom and dad 
236 (80.3) 131 (83.4) 105 (76.6) 122 (80.8) 114 (79.7) 
2 = Other 58 (19.7) 26 (16.6) 32 (23.4) 29 (19.2) 29 (20.3) 
 
 
represented by a White majority (Table 1).  In fact, White ethnicity composed at least 
70% of all of the samples, which may make it difficult to determine the effect of specific 
ethnic groups on certain factors.  Results of analyses using this variable will only reveal 
the effect of being White or not being White.  A vast majority (80%) of children reported 
living with their biological mom and dad (Table 1).  The remaining 20% was comprised 
of children living with their biological mom only, with their biological mom and step 
dad, with their biological mom and other relatives, and with adoptive or foster parents, 
combined.  Results of analyses using this variable will reveal the effect of living in a 
household with both biological parents versus living in a household that does not have 
both biological parents.   
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 The mean height of the entire sample was 60.40 ± 5.595 inches and the mean 
weight was 109.78 ± 37.802 pounds (Table 2).  Mean height and mean weight were 
greater in the adolescent sample compared to the pre-adolescent sample.  Likewise,  
mean height and mean weight are greater in males compared to females.  The mean BMI 
of the entire sample was 20.91 ± 5.080 (Table 2).  The mean BMI of the adolescent 
sample was greater than that of the pre-adolescent sample, and the mean BMI of males 
was greater than that of females.  BMI percentile was identified using the CDC growth 
charts, which was in turn used to determine overweight and at risk for overweight.  The 
mean BMI percentile of the entire sample was 64.61 ± 28.696 (Table 2).  In contrast to 
BMI, the mean BMI percentile of the pre-adolescent sample was greater than that of the 
adolescent sample.  The mean BMI percentile of the males was higher than that of the 
females.  While the mean BMI percentiles were within the healthy weight range for all 
samples, the standard errors for these statistics indicate that the confidence intervals for 
each of the samples included BMI percentiles that are considered at risk for overweight.  
More than half of the children in the entire sample fell into the category of healthy 
weight (Table 3).  Just below 20% of children were overweight and more than one-third 
of the children were either overweight or at risk for overweight.  Similar patterns were 
observed in the other samples as well.  More females were at a healthy weight compared 
to males, while a greater proportion of males than females were overweight or at risk for 
overweight.   
The mean waist circumference of the entire sample was 69.02 ± 12.738 cm 
(Table 3).  The mean waist circumference of the pre-adolescent sample (65.41 ± 11.213 
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TABLE 2  Sample size, mean, and standard error of height, weight, and BMI. 
 
 
Height (in) 
Entire 
Sample 
Pre-Adolescent  
(9-11 years) 
Adolescent 
(13-15 years) 
Male Female 
N 303 161 142 155 148 
Mean ± SE 60.40 ±  
5.595 
56.34 ± 3.494 64.99 ± 3.621 61.03 ±  
6.194 
59.73 ±  
4.821 
Weight (lb)      
N 303 161 142 155 148 
Mean ± SE 109.78 ±  
37.802 
88.60 ± 24.771 133.80 ± 35.650 113.89 ±  
37.902 
105.48 ±  
37.340 
BMI      
N 303 161 142 155 148 
Mean ± SE 20.91 ±  
5.080 
19.55 ± 4.380 22.45 ± 5.387 21.19 ±  
5.168 
20.62 ±  
4.988 
BMI percentile      
N 303 161 142 155 148 
Mean ± SE 64.61 ±  
28.696 
65.05 ± 29.454 64.12 ± 27.907 66.68 ±  
28.814 
62.45 ±  
25.508 
 
 
cm) was smaller than that of the adolescent sample (72.92 ± 13.049 cm).  Males had a 
larger mean waist circumference (70.04 ± 9.565 cm) than females (67.95 ± 11.716 cm).  
Mean hip circumference of the entire sample was 93.75 ± 13.764 cm (Table 3).  Similar 
to mean waist circumference, the mean hip circumference of the pre-adolescent sample 
(77.97 ± 10.859 cm) was smaller than that of the adolescent sample (90.31 ± 13.797 
cm).  In contrast to mean waist circumference, males had a lower mean hip 
circumference (82.96 ± 13.847 cm) than did females (84.58 ± 13.674 cm).  Waist and 
hip circumference were analyzed to determine waist/hip ratio, which has been used in 
research as a measure of central adiposity.  The mean waist/hip ratio of the entire sample 
was 0.83 ± 0.102 (Table 3).  Pre-adolescents had a larger waist/hip ratio (0.84 ± 0.071)  
compared to adolescents (0.81 ± 0.128), as did males (0.84 ± 0.073) compared to 
females (0.81 ± 0.124).   
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TABLE 3  Frequency (%) distributions for BMI category and waist and hip circumference. 
 
 
BMI category 
Entire 
Sample 
Pre-Adolescent 
(9-11 years) 
Adolescent 
(13-15 years) 
Male Female 
N 303  161  142  155  148  
1 = Underweight 3 (1.0) 1 (0.6) 2 (1.4) 2 (1.3) 1 (0.7) 
2 = Healthy weight 188 (62.0) 99 (61.5) 89 (62.7) 89 (57.4) 99 (66.9) 
3 = At risk for  
overweight 
56 (18.5) 30 (18.6) 26 (18.3) 30 (19.4) 26 (17.6) 
4 = Overweight 56 (18.5) 31 (19.3) 25 (17.6) 34 (21.9) 22 (14.9) 
Waist  
circumference (cm) 
     
N 303  161  142  155 148  
1 = Less than 50 6 (2.0) 3 (1.9) 3 (2.1) 5 (3.2) 1 (0.7) 
2 = 50 to 59 53 (17.5) 51 (31.7) 2 (1.4) 23 (14.8) 30 (20.3) 
3 = 60 to 69 124 (40.9) 61 (37.9) 63 (44.4) 55 (35.5) 69 (46.6) 
4 = 70 to 79 69 (22.8) 28 (17.4) 41 (28.9) 39 (25.2) 30 (20.3) 
5 = 80 to 89 31 (10.2) 13 (8.1) 18 (12.7) 22 (14.2) 9 (6.1) 
6 = 90 to 99 14 (4.6) 4 (2.5) 10 (7.0) 8 (5.2) 6 (4.1) 
7 = 100 or more 6 (2.0) 1 (0.6)  5 (3.5) 3 (1.9) 3 (2.0) 
Hip  
circumference (cm) 
     
N 303  161  142  155  148  
1 = Less than 50  6 (2.0) 2 (1.2) 4 (2.8) 4 (2.6) 2 (1.4) 
2 = 50 to 59 0 0 0 0 0 
3 = 60 to 69 36 (11.9) 35 (21.7) 1 (0.7) 21 (13.5) 15 (10.1) 
4 = 70 to 79 76 (25.1) 60 (37.3) 16 (11.3) 40 (25.8) 36 (24.3) 
5 = 80 to 89 88 (29.0) 42 (26.1) 46 (32.4) 41 (26.5) 47 (31.8) 
6 = 90 to 99 67 (22.1) 17 (10.6) 50 (35.2) 34 (21.9) 33 (22.3) 
7 = 100 or more 30 (9.9) 5 (3.1) 25 (17.6) 15 (9.7) 15 (10.1) 
Waist/hip ratio      
N 303  161  142  155  148  
1 = Less than 0.70 3 (1.0) 1 (0.6) 2 (1.4) 1 (0.6) 2 (1.4) 
2 = 0.70 to 0.74 28 (9.2) 2 (1.2) 26 (18.3) 3 (1.9) 25 (16.9) 
3 = 0.75 to 0.79 64 (21.1) 31 (19.3) 33 (23.2) 20 (12.9) 44 (29.7) 
4 = 0.80 to 0.84 103 (34.0) 58 (36.0) 45 (31.7) 61 (39.4) 42 (28.4) 
5 = 0.85 to 0.89 68 (22.4) 43 (26.7) 25 (17.6) 42 (27.1) 26 (17.6) 
6 = 0.90 to 0.94 25 (8.3) 20 (12.4) 5 (3.5) 19 (12.3) 6 (4.1) 
7 = 0.95 to 0.99  8 (2.6) 5 (3.1) 3 (2.1) 7 (4.5) 1 (0.7) 
8 = 1.00 to 1.99 3 (1.0) 1 (0.6) 2 (1.4) 2 (1.3) 1 (0.7) 
9 = 2.00 to 2.99 1 (0.3) 0 1 (0.7) 0 1 (0.7) 
 
 58 
 Triceps skinfold thickness and subscapular skinfold thickness may be used to 
estimate subcutaneous fat by using a skinfold caliper to measure skinfold thickness at 
respective locations on the body.  The mean triceps skinfold of the entire sample was 
15.95 ± 6.891 mm (Table 4).  Mean triceps skinfold measurement was slightly higher in 
pre-adolescents (16.13 ± 6.532 mm) than in adolescents (15.76 ± 7.296 mm).  Females 
had a higher mean triceps skinfold measurement (17.33 ± 6.284 mm) compared to males 
(14.65 ± 7.204 mm).  Reference values derived from the 1999-2002 NHANES report 
reference values for triceps skinfold measurements for children between the ages of 2 
and 19 years (91).  According to this report, triceps skinfold measurements between 21.4 
mm and 22.3 mm and between 21.6 mm and 18.8 mm are reference values for males 
aged 9 to 11 years and 13 to 15 years, respectively, who are at risk for overweight.  No 
reference values for triceps skinfold thickness were indicated for overweight males 
between the ages of 9 and 11 years or between 13 and 15 years.  Triceps skinfold 
measurements between 21.7 mm and 24.8mm and between 26.7 mm and 26.1 mm are 
reference values for females aged 9 to 11 years and 13 to 15 years, respectively, who are 
at risk for overweight.  A measurement of 33.4 was the only reference value indicated 
for triceps skinfold thickness for overweight females aged 13 years.  The mean 
subscapular skinfold measurement of the entire sample was 11.40 ± 6.930 mm (Table 4).  
The mean subscapular skinfold of adolescents (n=141, 11.97 ± 6.612 mm) was slightly 
larger than that of pre-adolescents (10.90 ± 7.181mm).  Females had a slightly higher 
mean subscapular skinfold (11.85 ± 7.251 mm) than did males (n=154, 10.97 ± 6.602 
mm).  According to the 1999-2002 NHANES report, subscapular skinfold  
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TABLE 4  Frequency (%) distributions for skinfold thickness measurements. 
  
Triceps  
skinfold (mm) 
Entire 
Sample 
Pre-Adolescent 
(9-11 years) 
Adolescent 
(13-15 years) 
Male Female 
N 303  161  142  155  148  
1 = Less than 5 2 (0.7) 0 2 (1.4) 2 (1.3) 0 
2 = 5 to 9 58 (19.1) 24 (14.9) 34 (23.9) 45 (29.0) 13 (8.8) 
3 = 10 to 14  84 (27.7) 54 (33.5) 30 (21.1) 41 (26.5) 43 (29.1) 
4 = 15 to 19 82 (27.1) 43 (26.7) 39 (27.5) 32 (20.6) 50 (33.8) 
5 = 20 to 24  41 (13.5) 24 (14.9) 17 (12.0) 22 (14.2) 19 (12.8) 
6 = 25 to 29 25 (8.3) 11 (6.8) 14 (9.9) 7 (4.5) 18 (12.2) 
7 = 30 to 34  8 (2.6) 3 (1.9) 5 (3.5) 5 (3.2) 3 (2.0) 
8 = 35 to 39 2 (0.7) 2 (1.2) 0 0 2 (1.4) 
9 = 40 or more 1 (0.3) 0 1 (0.7) 1 (0.6) 0 
Subscapular  
Skinfold (mm) 
     
N 302  161  141  154  148  
1 = Less than 5 12 (4.0) 9 (5.6) 3 (2.1) 8 (5.2) 4 (2.7) 
2 = 5 to 9 151 (50.0) 82 (50.9) 69 (48.9) 82 (53.2) 69 (46.6) 
3 = 10 to 14  75 (24.8) 38 (23.6) 37 (26.2) 30 (19.5) 45 (30.4) 
4 = 15 to 19 24 (7.9) 10 (6.2) 14 (9.9) 16 (10.4) 8 (5.4) 
5 = 20 to 24  16 (5.3) 9 (5.6) 7 (5.0) 7 (4.5) 9 (6.1) 
6 = 25 to 29 14 (4.6) 9 (5.6) 5 (3.5) 8 (5.2) 6 (4.1) 
7 = 30 to 34  9 (3.0) 3 (1.9) 6 (4.3) 3 (1.9) 6 (4.1) 
8 = 35 to 39 0 0 0 0 0 
9 = 40 or more 1 (0.3) 1 (0.6) 0 0 1 (0.7) 
 
 
measurements between 13.3 mm and 17.2 mm are reference values for males aged 9 to 
11 years and 13 to 15 years, respectively, who are at risk for overweight (91).  A  
measurement of 25.0 mm was the only reference value indicated for subscapular 
skinfold thickness for overweight males aged 13 years.  Subscapular skinfold 
measurements between 15.4 mm and 17.9 mm and between 20.8 mm and 22.1 mm are 
reference values for females aged 9 to 11 years and 13 to 15 years, respectively, who are 
at risk for overweight.  A measurement of 30.8 mm was the only reference value 
indicated for subscapular skinfold thickness for females aged 13 years. 
 60 
 Less than 4% of the children in the entire sample had been diagnosed with 
allergies (Table 5).  Twice as many adolescents had been diagnosed with allergies 
compared to pre-adolescents.  Males and females had similar rates of diagnosed 
allergies.  Almost six times more children in the entire sample have been diagnosed with 
asthma compared to allergies (Table 5).  More adolescent children were diagnosed with 
asthma compared to pre-adolescent children.  Approximately 20% of both males 
and females were reported to be diagnosed with asthma.  More children in the entire 
sample were reported to be taking prescription medication for allergies than were 
reported to be diagnosed with allergies (Table 5).  Although more adolescent  
children than pre-adolescent children were diagnosed with allergies, more pre-adolescent 
children were reported to be taking prescription medication for allergies compared to  
 
 
TABLE 5  Frequency (%) distributions of allergy and asthma diagnoses and medication use. 
 
 
Allergies 
Entire 
Sample 
Pre-Adolescent 
(9-11 years) 
Adolescent 
(13-15 years) 
Male Female 
N 299  159  140  152 147  
0 = No 288 (96.3) 155 (97.5) 133 (95.0) 146 (96.1) 142 (96.1) 
1 = Yes 11 (3.7) 4 (2.5) 7 (5.0) 6 (3.9) 5 (3.9) 
Allergy RX      
N 299  159 140  152  147  
0 = No 274 (91.6) 144 (90.6) 130 (92.9) 141 (92.8) 133 (90.5) 
1 = Yes 25 (8.4) 15 (9.4) 10 (7.1) 11 (7.2) 14 (9.5) 
Asthma      
N 299  159  140  152  147  
0 = No 235 (78.6) 130 (81.8) 105 (75.0) 120 (78.9) 115 (78.2) 
1 = Yes 64 (21.4) 29 (18.2) 35 (25.0) 32 (21.1) 32 (21.1) 
Asthma RX      
N 299  159  140  152  147  
0 = No 277 (92.6) 148 (93.1) 129 (92.1) 141 (92.8) 136 (92.5) 
1 = Yes 22 (7.4) 11 (6.9) 11 (7.9) 11 (7.2) 11 (7.5) 
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adolescent children.  Likewise, more females than males were reported to be taking 
prescription medication for allergies.  Fewer children in the entire sample were reported 
to be taking prescription medication for asthma than for allergies despite a higher 
diagnosis rate for asthma (Table 5).  More adolescent children compared to pre-
adolescent children were reported to be taking prescription medication for asthma.  Less 
than 10% of both males and females were reported to be taking prescription medication 
for asthma.   
 The mean dietary omega-3 fatty acid intake of the entire sample was 0.51 ± 
0.366 grams (Table 6).  Both the mean intake of the pre-adolescent sample and the 
adolescent sample were similar to that of the entire sample.  The mean intake of males 
was higher than that of females.  According to intake, less than 5% of the children in the  
entire sample met the AI for dietary omega-3 fatty acid.  A smaller proportion of 
children with asthma (3.3%) met the omega-3 fatty acid AI compared to children 
without asthma (4.9%).  More pre-adolescent children than adolescent children met  
the AI for dietary omega-3 fatty acid.  A smaller proportion of pre-adolescent children 
with asthma (3.6%) met the omega-3 fatty acid AI compared to pre-adolescent children 
without asthma (5.6%).  A smaller proportion of adolescent children with asthma (3.0%) 
met the omega-3 AI compared to adolescent children without asthma (4.0%).  More than 
twice as many females met the AI for dietary omega-3 fatty acid compared to males.  
None of the males with asthma met the omega-3 fatty acid AI.  The proportion of 
females with asthma (6.5%) who met the omega-3 fatty acid AI was similar to that of 
females without asthma (6.2%).  Only 1% of the children in the entire sample reported  
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TABLE 6  Frequency (%) distributions of dietary intake and supplement use. 
 
Omega-3 fatty  
acid intake (g) 
Entire 
Sample 
Pre-Adolescent 
(9-11 years) 
Adolescent 
(13-15 years) 
Male Female 
N 289 153 136 145 144 
Mean 0.51 0.51 0.51 0.55 0.48 
Standard error 0.366 0.399 0.327 0.382 0.347 
Met omega-3  
fatty acid AI 
     
N 289  153  136  145  144  
0 = No 276 (95.5) 145 (94.8) 131 (96.3) 141 (97.2) 135 (93.8) 
1 = Yes 13 (4.5) 8 (5.2) 5 (3.7) 4 (2.8) 9 (6.3) 
Omega-3 fatty  
acid supplement 
     
N 303  161  142  155  148  
0 = No 300 (99.0) 158 (98.1) 142 (100) 152 (98.1) 148 (100) 
1 = Yes 3 (1.0) 3 (1.9) 0 3 (1.9) 0 
Vitamin C 
 intake (mg) 
     
N 289 153 136 145 144 
Mean ± SE 73.67 ±  
53.729 
74.77 ±  
52.878 
72.44 ±  
54.840 
76.06 ±  
55.074 
71.27 ±  
54.422 
Met vitamin C  
DRI 
     
N 289  153  136  145  144  
0 = No 137 (47.4) 58 (37.9) 79 (58.1) 71 (49.0) 66 (45.8) 
1 = Yes 152 (52.6) 95 (62.1) 57 (44.1) 74 (51.0) 78 (54.2) 
Vitamin C  
supplement 
     
N 303  161  142  155  148  
0 = No 274 (90.4) 144 (89.4) 130 (91.5) 137 (88.4) 137 (92.6) 
1 = Yes 29 (9.6) 17 (10.6) 12 (8.5) 18 (11.6) 11 (7.4) 
Multi-vitamin/ 
mineral  
     
N 303  161  142  155  148  
0 = No 189 (62.4) 97 (60.2) 92 (64.8) 103 (66.5) 86 (58.1) 
1 = Yes 114 (37.6) 64 (39.8) 50 (35.2) 52 (33.5) 62 (41.9) 
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taking an omega-3 fatty acid supplement (Table 6).  Approximately 2% of both the pre-
adolescents and males reported taking an omega-3 fatty acid supplement, while none of 
the adolescent children or females report taking such a supplement.  The mean dietary 
vitamin C intake of the children of the entire sample was 73.67 ± 53.729 mg (Table 6).  
The mean dietary vitamin C intake of pre-adolescent children was just higher than that 
of adolescent children.  Like dietary omega-3 fatty acid intake, dietary vitamin C intake 
was higher in males than in females.  According to this intake, just over half of the 
children in the entire sample met the DRI for dietary vitamin C (Table 6).  A larger 
proportion of children with asthma (59.1%) met the vitamin C DRI compared to children 
without asthma (51.1%).  More pre-adolescent children met the DRI for dietary vitamin 
C compared to adolescent children.  A larger proportion of pre-adolescent children with 
asthma met the vitamin C DRI (67.9%) compared to pre-adolescent children without 
asthma (61.3%).  A larger proportion of adolescent children with asthma (51.5%) met 
the vitamin C DRI compared to adolescent children without asthma (38.6%).  A slightly 
higher proportion of females than males met the DRI for dietary vitamin C.  A larger 
proportion of males with asthma (60.0%) met the vitamin C DRI compared to males 
without asthma (49.1%).  A larger proportion of females with asthma (58.1%) met the 
vitamin C DRI compared to females without asthma (53.1%).  Few children in the entire 
sample reported taking a vitamin C supplement (Table 6).  More pre-adolescents than 
adolescents and more males than females reported taking such a supplement.  Just over 
one-third of the children in the entire sample reported taking a multi-vitamin/mineral 
supplement (Table 6).  A larger proportion of pre-adolescent children than adolescent 
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children reported taking a multi-vitamin/mineral supplement.  More females than males 
also reported taking such a supplement.   
Binary Regression Analysis 
Results of binary regression analysis performed on the entire sample (Table 7) 
revealed that children of ethnicities other than White were more likely to be diagnosed 
with asthma and were more likely to be using asthma medications than children of White 
ethnicity.  Children who reported the use of vitamin C supplements were more likely to 
be diagnosed with allergies.  Children who were using allergy medications were more 
likely to have asthma and to be using asthma medications compared to children who 
were not using allergy medications.  Likewise, children who were using asthma 
medications or who had been diagnosed with asthma were more likely to be using 
allergy medications than children who were not using asthma medications.  Neither 
vitamin C intake, omega-3 fatty acid intake, weight, BMI, nor any anthropometric 
measurements were found to be statistically related to asthma diagnosis. 
 
 
TABLE 7  Results of binary regression performed on the entire sample. 
 
Dependent Variable Covariate Wald Sig. Odds Ratio 
Asthma Ethnicity 3.931 P<0.05 1.810 
 
Allergy RX 90.347 P<0.01 4.737 
Allergies Vitamin C Supplement 7.368 P<0.01 6.011 
 
Activity 4.573 P<0.05 3.148 
 
Hard exercise 4.463 P<0.05 0.575 
Asthma RX Ethnicity 7.801 P<0.01 3.515 
 
Allergy RX 5.653 P<0.05 3.779 
Allergy RX Asthma 13.123 P<0.01 4.737 
 
Asthma RX 5.653 P<0.05 3.779 
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 The results of binary regression analysis performed on the pre-adolescents (Table 
8) demonstrated correlations between asthma diagnosis and weight, BMI, BMI category, 
subscapular skinfold, and waist circumference.  More specifically, children with larger 
subscapular skinfolds, children with larger waist circumferences, and children who were 
overweight were all more likely to be diagnosed with asthma compared to their 
counterparts.  Several anthropometric measurements were found to be significantly 
correlated with the use of asthma medications as well.  Children with higher weights, 
higher BMI’s, larger subscapular skinfolds, and larger waist circumferences were more 
likely to be using asthma medications.   
 Results of binary logistic regression analysis of the adolescents (Table 9) found 
that the older children in this age group were less likely to be diagnosed with asthma and 
also less likely to be using asthma medications.  In contrast to the results we saw 
regarding weight and asthma diagnosis in the previous sample, in this sample, children 
with higher weights were less likely to be diagnosed with asthma than children with 
lower weights.  The odds of asthma diagnosis were very high for children using allergy 
medications.  Children who were reported to be using allergy medications also had 
greater odds of being diagnosed with allergies and of using asthma medications.   
Children who were reported to be using asthma medications were more likely to be 
using allergy medications compared to children who were not using asthma medications.  
The odds of using asthma medications were greater for children who were not of White 
ethnicity.  The odds of using asthma medications were also greater for children with 
asthma whose mothers were overweight.  Vitamin C supplementation was associated  
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TABLE 8  Results of binary regression performed on pre-adolescents. 
 
Dependent Variable Covariate Wald Sig. Odds Ratio 
Asthma BMI category 4.893 P<0.05 1.709 
 
Subscapular skinfold 4.096 P<0.05 1.302 
 
Waist circumference 4.213 P<0.05 1.452 
Asthma RX Weight 4.602 P<0.05 1.022 
 
BMI 4.405 P<0.05 1.128 
 
BMI category 4.705 P<0.05 2.184 
 
Subscapular skinfold 5.228 P<0.05 1.481 
 
Waist circumference 4.124 P<0.05 1.683 
 
 
 
TABLE 9  Results of binary regression performed on adolescents. 
 
Dependent Variable Covariate Wald  Sig. Odds Ratio 
Asthma Age 9.505 P<0.01 0.445 
 
Weight 4.278 P<0.05 0.986 
 
Allergy RX 11.056 P<0.01 15.259 
Allergies Vitamin C Supplement 7.764 P<0.01 10.333 
 
Allergy RX 9.227 P<0.01 13.500 
Asthma RX Ethnicity 6.109 P<0.05 5.089 
 
Age 6.266 P<0.05 0.299 
 
Allergy RX 5.783 P<0.05 6.536 
 
Mom BMI category 4.639 P<0.05 2.253 
Allergy RX Allergies 9.227 P<0.01 13.500 
 
Asthma 11.056 P<0.01 15.259 
 
Asthma RX 5.783 P<0.05 6.536 
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with greater odds of allergy diagnosis.  Children with an allergy diagnosis were more 
likely to be using allergy medications compared to children without allergies.  Children 
with an asthma diagnosis were also more likely to be using allergy medications than 
children who did not have asthma.  As in the results of the entire sample, neither BMI 
nor anthropometric measurements were found to be significantly related to asthma 
diagnosis. 
 Tables 10 and Table 11 list the results of binary logistic regression analysis 
performed on males and females, respectively.  As in the pre-adolescent sample, the 
odds of asthma diagnosis were increased for overweight males.  Allergy diagnosis and 
the use of allergy medications also increased the odds of asthma diagnosis in males.  
Asthma was not significantly related to any other variables in females.  In males, the 
odds of allergy diagnosis were increased for children who were using vitamin C 
supplements, who had larger triceps and subscapular skinfolds, who were using asthma 
medications, and who were reported to be diagnosed with asthma.  Neither vitamin C 
supplementation, subscapular skinfold, the use of asthma medications, nor asthma 
diagnosis were significantly correlated with the use of allergy medications in females.  
Females with larger triceps skinfolds were less likely to be diagnosed with allergies than  
females with smaller triceps skinfolds.  Children who were not of White ethnicity and 
children who were using allergy medications were more likely to be using asthma 
medications.  Neither of these variables was associated with the use of asthma 
medications in females.  Instead, females with asthma whose mothers were overweight 
were more likely to be using asthma medications.  The odds of using allergy medications  
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were increased by allergy diagnosis in both males and females.  In males, these odds 
were also increased by asthma diagnosis and the use of asthma medications.  In none of 
the samples discussed in this section were dietary intake, multi-vitamin/mineral or 
omega-3 fatty acids supplementation, guardian, waist/hip ratio, mom’s smoking habit, or 
mom’s education significantly related to any of the dependent variables that were 
analyzed, including asthma and allergy diagnosis and the use of asthma or allergy 
medications. 
 
 
TABLE 10  Results of binary regression performed on males. 
 
Dependent Variable Covariate Wald Sig. Odds Ratio 
Asthma BMI category 4.173 P<0.05 1.605 
 
Allergies 5.721 P<0.05 8.429 
 
Allergy RX 9.935 P<0.01 8.120 
Allergies Vitamin C supplement 6.338 P<0.05 8.733 
 
Activity 4.730 P<0.05 4.927 
 
Hard exercise 6.742 P<0.01 0.294 
 
Triceps skinfold 6.316 P<0.05 1.887 
 
Subscapular skinfold 4.899 P<0.05 1.716 
 
Allergy RX 4.744 P<0.05 7.611 
 
Asthma 5.721 P<0.05 8.429 
Asthma RX Ethnicity 5.836 P<0.05 4.870 
 
Allergy Rx 5.668 P<0.05 6.234 
Allergy RX Activity 4.760 P<0.05 3.268 
 
Allergies 4.744 P<0.05 7.611 
 
Asthma 9.935 P<0.01 8.120 
 
Asthma RX 5.668 P<0.05 6.234 
 
 
 
TABLE 11  Results of binary regression performed on females. 
 
Dependent Variable Covariate Wald Sig. Odds Ratio 
Allergies Triceps skinfold 7.191 P<0.01 0.114 
 
Allergy RX 4.229 P<0.05 7.222 
Asthma RX Mom BMI category 4.567 P<0.05 2.248 
Allergy RX Allergies 4.229 P<0.05 7.222 
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CHAPTER V 
DISCUSSION 
 
This chapter will discuss the variable frequency distributions and the outcomes of 
linear regression analysis and logistic regression analysis in more detail.  It will also 
explain the significance and importance of these outcomes.  Following these discussions, 
this chapter will provide information regarding limitations of this thesis project as well 
as provide suggestions for future research endeavors. 
The result that adolescent children were taller and weighed more than pre-
adolescent children was expected.  Puberty, the factor separating these two samples is 
followed by a time of marked growth.  In general, older children who have experienced 
puberty are taller and therefore weigh more than younger children who have not yet 
experienced puberty.  Boys are usually taller than girls, therefore, the results that males 
were taller and weighed more than females was also expected.  BMI, a measure of 
weight for height, is expected to be larger for taller children, who incidentally weigh 
more.  This is consistent with the results of this analysis.  Adolescent children, who were 
taller and weighed more than pre-adolescent children, had higher BMI’s.  Likewise, 
males, who were taller and weighed more than females, also had higher BMI’s.  Because 
children at different ages are experiencing different rates of growth and maturation, BMI 
percentile can determine an individual’s level of growth and maturation in comparison to 
others of the same age.  In this study, we found that pre-adolescents tend to have higher 
BMI percentile scores than adolescent children.  This reveals that more pre-adolescent 
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children than adolescent children in this study had weights for height that exceed those 
of their peers.  A possible explanation for this would be that, compared to their peers, the 
adolescents in this sample have not yet experienced a growth spurt.  More males than 
females have weights for height that exceed those of their peers.  Perhaps more males in 
this study, compared to other males have experienced a growth spurt, while fewer 
females in this study, compared to other females have not.  Children with a BMI that lies 
above the 95th percentile, and perhaps even above the 85th percentile, are of concern 
because they may be at increased health risk.  The finding that just fewer than 20% of 
children are above the 95th percentile is close to the national average of 17%, but slightly 
lower than average for the state of Texas.  Results also showed that more than one-third 
of the children in this study were above the 85th percentile, and possibly at increased 
health risk.  In particular, more males than females and slightly more pre-adolescents 
than adolescents fell into this category.   
Children who were taller and who weighed more were expected to have larger 
waist and hip circumferences than children who were shorter and who weighed less.  
Results of this analysis confirm this.  Adolescent children had larger waist and hip 
circumferences than pre-adolescent children, and males had larger waist and hip 
circumferences than females.  Waist/hip ratio has been used by some researchers as an 
estimate of central adiposity.  In order to include this measurement in analyses, waist 
and hip circumferences of the children in this study were compared.  Under normal 
circumstances, hip circumference is larger than waist circumference.  A higher ratio 
indicates an increasing waist circumference that is approaching the measure of the hip 
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circumference.  In theory, individuals who become overweight accumulate fat in their 
abdomen, which results in an increasing waist circumference but little change in hip 
circumference.  For this reason, waist/hip ratio has been used as a measure of central 
adiposity.  We found that adolescents had higher waist/hip ratios than pre-adolescents.  
Likewise, males had higher waist/hip ratios compared to females.  Interestingly, this 
corresponded with the results we discovered earlier that a larger proportion of both pre-
adolescents and males were above the 85th BMI percentile.  This finding supported the 
use as waist/hip ratio in this study as a possible indicator of central adiposity and 
suggested that more pre-adolescents and males were overweight.  Overall body fat is 
often estimated through a series of skinfold measurements at specific locations on the 
body.  The triceps and the subscapular area are two areas of the body which are targeted 
in this process.  Analysis of triceps skinfold thickness and subscapular skinfold thickness 
revealed that pre-adolescents had thicker triceps skinfolds, while adolescents had thicker 
subscapular skinfolds.  Distribution of body fat may differ between pre-adolescent and 
adolescent children because of differences in growth patterns.  Females had both thicker 
triceps skinfolds and subscapular skinfolds compared to males.  Males, in general, tend 
to have more lean body mass, which may explain why skinfolds were thicker in females.  
Differing body fat distributions between males and females may also partially explain 
these results.   
Very few children in this study had received a diagnosis of allergies.  Allergy 
prevalence in this study was much lower than the prevalence reported for the U.S (11%) 
and for the South (15%).  Males and females had similar rates of diagnosis, but allergies 
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seemed to be more prevalent among adolescent children than among pre-adolescent 
children.  One possible explanation for this difference is that older children have more 
autonomy and are more likely to explore their environment, thereby exposing 
themselves to more environmental allergens.  They, therefore, are more likely than pre-
adolescents to experience more allergy symptoms, which may then lead to a higher rate 
of allergy diagnosis.  Many more children in this study were found to be diagnosed with 
asthma than to be diagnosed with allergies.  Approximately 20% of children received a 
diagnosis of asthma, which is much higher that the average number of children in the 
U.S. who received an asthma diagnosis just two years ago.  It is also higher than the 
prevalence rate in Texas, reported by Petronella et al.  Similar to allergy diagnosis, males 
and females had similar rates of asthma diagnosis, but adolescents had higher rates of 
asthma diagnosis than pre-adolescents.  This supports the idea that childhood asthma is 
more commonly allergic asthma, since more adolescents had allergies and asthma.  
Interestingly, the rate of allergy medication use was much higher than the rate of allergy 
diagnosis.  This may be explained by under-reporting of allergy diagnosis or the misuse 
of allergy medications.  Although more adolescent children had been diagnosed with 
allergies, more pre-adolescent children were reported to be using allergy medications.  
Perhaps pre-adolescent children had not received a physician diagnosis of allergies, 
mothers of pre-adolescents did not report allergy diagnosis to the interviewer, or allergy 
medications were being misused by pre-adolescents.  Or, perhaps, adolescents 
experienced milder allergy symptoms that did not warrant the use of medications.  More 
females than males were also reported to be using allergy medications despite similar 
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rates of allergy diagnosis.  This could also be due to under-reported allergy diagnosis in 
females or the misuse of allergy medications by females.  Females may have reported 
more symptoms of allergy and therefore were more likely to use medications, or males 
may have experienced milder allergy symptoms that did not require the use of 
medications.  The use of asthma medications was less frequently reported than the use of 
allergy medications, despite a higher rate of asthma diagnosis.  If the asthma experienced 
by the children in this study is allergic asthma, then perhaps the higher rate of allergy 
medication use reflects the attempt to control the allergy symptoms that trigger asthma.  
More adolescent children were reported to be using asthma medications, which was 
expected since more adolescent children were reported to have an asthma diagnosis.  A 
similar rate of asthma medication use in males and females likely reflected the similar 
rates of asthma diagnoses in these two samples.   
The mean dietary omega-3 fatty acid intake and the mean dietary vitamin C 
intake among the children in this study were both below recommendations for these 
nutrients.  These nutrients provide protective effects against health risks as mentioned in 
a previous chapter; therefore, dietary intake of these nutrients is of concern.  Vitamin C 
is found abundantly in fresh fruits and vegetables, consequently a low vitamin C intake 
likely reflects low fruit and vegetable consumption.  Despite a higher dietary intake of 
vitamin C, fewer males are met the vitamin C DRI compared to females.  The vitamin C 
DRI for males is higher than for females, which may explain why fewer males met 
recommendations.  Likewise, more pre-adolescent than adolescent children met the DRI 
for vitamin C, probably due to lower recommendations.  While half of the children in 
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this study were reported to be meeting the recommended intake for vitamin C, very few 
children were meeting recommended intake for omega-3 fatty acid.  The AI for omega-3 
fatty acid intake is lower for females and for pre-adolescents, which likely explains why 
more of these children met the recommendations for this nutrient compared to their 
counterparts.  Few children in this study reported taking a vitamin C supplement, and 
even fewer reported taking an omega-3 fatty acid supplement.  For both supplements, 
reports were higher among pre-adolescents compared to adolescents and among males 
compared to females.  It may be that supplements were being used in conjunction with 
prescription medications to treat medical conditions, which may explain why pre-
adolescents, who had a higher rate of allergy medication use, also had a higher rate of 
supplement use compared to adolescents.  Or, perhaps supplements were used as an 
alternative to prescription medications, which may explain why the rate of allergy 
medication was lower in males, but the rate of supplement use was higher compared to 
females.  If the low intakes of vitamin C reported here reflect low intakes of fruits and 
vegetables, it is likely that other vitamins and minerals may be lacking in the diet as 
well.  Like the previously mentioned supplements, the use of a multi-vitamin/mineral 
supplement was reported to be higher among pre-adolescents compared to adolescents, 
perhaps reflecting their use in conjunction with prescription medications.  In contrast to 
the previous example of supplement use, more females than males were reported to be 
taking a multi-vitamin/mineral supplement.  Females may be more health-conscious and, 
therefore, more likely to use a multi-vitamin/mineral supplement.   
 75 
Logistic regression analysis revealed that the use of allergy medications was 
positively correlated with asthma diagnosis.  It has been suggested that allergic asthma is 
the most common type of asthma among children, which is supported by these results.  
BMI category was found to be positively correlated with asthma diagnosis in pre-
adolescents and in males.  Perhaps pre-adolescence is a vulnerable time during which 
asthma is adversely affected by overweight.  A lower prevalence of overweight among 
females in this sample may have resulted in no correlation between BMI and asthma 
diagnosis.  Waist circumference and subscapular skinfold were also found to be 
positively correlated with asthma diagnosis in pre-adolescents.  BMI category was 
related to asthma diagnosis in pre-adolescents perhaps because this group of children 
had not yet experienced marked growth in height, so increases in weight would increase 
weight for height ratio.  The relationship between asthma and waist circumference and 
between asthma and subscapular skinfold supports the idea that asthma may be related to 
adipose tissue.  Age and weight appeared to be inversely related to asthma diagnosis in 
adolescents, suggesting that the younger children in this sample were more likely to be 
diagnosed with asthma.  Perhaps asthma improved as age increases, or perhaps older 
children perceived their asthma to be better than it actually was.  Weight may be a factor 
as a consequence of age.  Younger children may not have experienced peak growth and 
consequently weigh less than older children.   
Vitamin C supplementation was found to be positively correlated with allergy 
diagnosis among the children in this study, more particularly among adolescents and 
males.  This may be due to the replacement of prescription medications by vitamin C for 
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the treatment of allergies.  Adolescents had higher rates of asthma diagnosis but lower 
rates of medication use than pre-adolescents.  Males had lower rates of allergy 
medication use compared to females, despite similar rates of allergy diagnosis.   
 The use of allergy medications was found to be positively correlated with the use 
of asthma medications.  This supports the notion that the children in this study had 
allergic asthma, and were therefore treating their asthma directly through the use of 
asthma medications and indirectly through the use of allergy medications.  BMI, BMI 
category and mother’s BMI category were also found to be positively correlated with the 
use of asthma medications.  If, in fact, overweight children are more likely to be 
diagnosed with asthma, then they would consequently be more likely to use asthma 
medications.  If mothers are overweight, then children are more likely to be overweight, 
and therefore more likely to have asthma and use asthma medications.  Age was 
inversely related to the use of asthma medications in adolescents.  As mentioned 
previously, younger children were more likely to have asthma and as a result were more 
likely to use asthma medications.  Asthma may have improved with age, thereby 
required less use of asthma medications.  Because increasing waist circumference and 
subscapular skinfold thickness were found to increase the risk of asthma diagnosis, the 
finding that these factors were also associated with the use of asthma medications is not 
surprising.  Diagnosis with allergies was found to increase the likelihood of allergy 
medication use, which was expected.  Diagnosis with asthma and the use of asthma 
medications also increased the likelihood of allergy medication use.  Again, this is most 
likely due to the presence of allergic asthma among the children in this study.   
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 Positive correlations were found between ethnicity and asthma and between 
ethnicity and asthma medication use.  This finding suggests that children of ethnicities 
other than White were more likely to be diagnosed with asthma and to be using asthma 
medications.  This finding is consistent with the research that suggests asthma is more 
prevalent among minorities, such as Blacks and Hispanics.  However, given the small 
sample size of minorities in this study, it would be difficult to specify which minority 
population was at higher risk for asthma.   
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CHAPTER VI 
SUMMARY 
 
 In the present study, overweight children, as determined by BMI category, were 
at risk for asthma and the use of asthma medications.  These children may have 
experienced more asthma symptoms which led them to seek medical care and therefore 
to receive an asthma diagnosis.  Overweight children were also at risk for the use of 
allergy medications, which suggests that overweight children may have been taking 
multiple medications, which is consistent with research.  Perhaps this is due to an 
inflammatory response initiated by adipose tissue, as discussed in an earlier chapter.  
Likewise children with large waist circumferences were at risk for asthma.  Research has 
shown that waist circumference is associated with greater health risk among adults.  
More specifically, waist circumferences above 35 inches (88 cm) in women and 40 
inches (102 cm) in men increase health risks (40).  No such threshold values exist for 
children, making it difficult to establish that children with very large waist 
circumferences are at increased health risk, but the findings in this study suggest that 
they may be.  Anthropometric measurements were also found to be positively correlated 
with asthma diagnosis, suggesting that children with excess body fat may be at risk for 
asthma.  However, without having skinfold measurements from at least two additional 
sites on the body, it is difficult to determine total body fat composition.  This makes it 
difficult to determine whether these correlations are actually due to body fat percentage 
or just due to differing fat distributions throughout the body.  Children with asthma were 
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likely to be taking allergy medications despite the lack of an allergy diagnosis, 
suggesting that these children may have allergic asthma.  They may have been 
prescribed allergy medications by their physicians in an attempt to treat the allergies that 
caused their asthma.  Children who use vitamin C supplements were likely to have 
allergies, perhaps because these children were aware of their allergies and were using 
vitamin C to treat their symptoms.  In this study, no significant correlations were found 
between asthma diagnosis and waist/hip ratio, dietary intake, guardian, smoking by the 
mother, or the mother’s level of education, suggesting that these factors may not 
significantly contribute to asthma.   
Limitations 
The findings in this study are not without limitations.  The number of children 
who reported asthma and allergies was small, making it difficult to establish many 
correlations with their diagnoses.  This was likely due to the fact that this survey was not 
designed specifically to obtain information on asthma or allergies.  Very few of the 
many questions in this survey were asked regarding health conditions, and there were no 
questions regarding asthma symptoms and/or spirometry.  This made it difficult to 
determine asthma severity and control, or to possibly identify undiagnosed asthma.  Skin 
prick tests were not performed, which may have better identified children with allergies.  
Diagnosis of asthma in the child was defined as the report of asthma by the mother.  This 
may lead to under-reporting or perhaps even over-reporting of medical conditions.  
Consulting medical records would be preferred but much more time consuming and 
invasive.  On the other hand, physicians may not use the same criteria to diagnose 
 80 
asthma (17, 33), which could also have affected the number of reported asthma cases in 
this study.  Because this was a survey, there was no follow-up.  Information at one point 
in time was obtained, making it impossible to determine if responses to questions change 
over time.  If more children became overweight, would more develop asthma?  As 
children grow older, do more grow out of their childhood asthma?  The nature of this 
study also makes it difficult to determine a causal relationship between asthma and 
overweight in children.  It is impossible to determine which occurred first.  Finally, the 
regression analyses performed in this study were simple regression tests, which may not 
have accounted for possible confounding variables. 
Future Research 
In order to assure that asthma and allergy are well represented, future studies should 
be designed to target these populations specifically.  This will better predict possible risk 
factors for the development of both conditions.  Preferably, these studies should be 
longitudinal in nature, allowing the establishment of the time of onset of asthma or 
allergies and their risk factors, such as overweight.  Physicians, as well as researchers, 
should agree upon a definition of asthma and unanimous criteria should be established in 
order to diagnosis the condition correctly and consistently.  Future analyses performed 
on asthma and its possible risk factors should be more specific, including possible 
confounding factors.  This should be done so in order to eliminate false correlations.   
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